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ABSTRACT
Trypanosoma brucei, a unicellular eukaryotic parasite, is the causative agent of
African sleeping sickness in sub-Saharan Africa. The parasite encounters two main
environments as it progresses through its life cycle: the tsetse fly and the mammalian
bloodstream. Nutrient availability is distinct in the two environments, requiring the
parasite to utilize diverse metabolic pathways to efficiently produce ATP for survival.
Bloodstream form parasites (BSF), residing in a glucose rich environment, rely solely on
glycolysis for energy, while procyclic form (PF) parasites metabolize readily available
proline and threonine in addition to glucose.
T. brucei expresses two hexokinases, the first enzyme in the glycolytic pathway,
that are 98.5% identical at the nucleotide level and 98% similar at the amino acid level.
These two enzymes, TbHK1 and TbHK2, are differentially expressed in both BSF and PF
parasites. Here, I identify a means of regulation of TbHK1 gene expression and a novel
mechanism for regulating TbHK1 enzyme activity. Lastly, I have characterized, the
bioflavonoid quercetin, a small molecule regulator TbHK1.
Mechanisms involved in regulating TbHK1 and TbHK2 gene expression have not
been extensively studied. I have found that TbHK1 uses differential polyadenylation to
regulate gene expression in variable environmental conditions. A recent study by Siegel
et al. (2010), revealed that TbHK1 contains seven predominant polyadenylation sites,
whereas, TbHK2 contains only one. Using a reporter gene system to assess transcript
level and protein expression, I have determined that these seven different 3’UTR lengths
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result in differential steady state transcript abundance and expression level, dependent on
nutrient availability.
Further, I have identified a novel means of regulation of TbHK1 enzyme activity.
Enzymatic studies of recombinant TbHK1 reveal that TbHK is inactivated under acidic
conditions. However, the addition of glycerol-3-phosphate to the reaction at acidic pH
maintained T. brucei hexokinase activity. I propose this regulation may play an
important role in the biology of the parasite during differentiation and subsequent
acidification of glycosomes, the peroxisomal like organelle that houses glycolytic
enzymes.
Lastly, the TbHKs were identified as possible drug targets because they are
essential to the BSF parasite and only ~30% similar to human glucokinase, the human
equivalent of TbHK1. We have found that quercetin, a known trypanocide, is a potent
inhibitor of TbHK1. Further, taking advantage of the fluorescent nature of the
compound, I found that the compound localizes to the same subcellular compartment that
houses TbHK1 and interacts with the protein near the active site as a mixed inhibitor.
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CHAPTER ONE
LITERATURE REVIEW
Trypanosoma brucei, a single-celled eukaryotic parasite, is the causative agent of African
sleeping sickness, affecting 50-70,000 people in 36 countries of sub-Saharan Africa (Brun,
2010). There are three subspecies of T. brucei: T. brucei brucei, T. brucei rhodesiense, and T.
brucei gambiense, with the latter two subspecies being infective to humans. T. b. gambiense is
endemic to west and central Africa and causes a chronic form of trypanosomiasis, whereas T. b.
rhodesiense is prevalent in east and southern Africa and causes an acute form of the disease. T.
b. brucei is not infective to humans, but instead infects wild and domestic animals causing a
disease termed nagana (Brun et al., 2010).
The parasite is transmitted to the mammalian host by the bite of an infected tsetse fly
(Glossina genus) (Jordan, 1993). Upon transmission from the fly into the bloodstream of the
human host, the parasite lives and divides, with the first signs of infection being fever and joint
pain. Currently, treatment is available for this stage of trypanosomiasis, however, it is often
undiagnosed and in turn untreated (Doua et al., 1996). If left untreated, the parasite load
increases in the infected individual and eventually crosses the blood-brain barrier and infects the
central nervous system causing symptoms such as disturbance in sleep patterns and confusion
(Buguet et al., 2006; Kennedy, 2006). Trypanosome infection is always fatal if left untreated
(Brun et al., 2010). Treatment currently available for this stage of the disease is toxic, killing up
to 10% of patients and requires high doses typically delivered by intravenous administration over
several days to be effective (Schmid et al., 2005).
According to the World Health Organization, African sleeping sickness is considered a
neglected tropical disease and remains an important public health issue (Brun et al., 2010). As
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aforementioned, treatments currently available for African sleeping sickness are toxic and hard
to administer, therefore, identification of potential drug targets to develop alternative therapeutic
options for treatment of trypanosomiasis is a priority of research. Current T. brucei research,
however, is not only focused on elucidating a treatment for disease, but also understanding the
cell biology of the organism, including cell structure, organelle positioning, protein trafficking
and cell division (Matthews, 2005) – these efforts may identify new targets for therapeutic
development.

I. LIFE CYCLE OF T. BRUCEI
T. brucei spends its life in two distinct environments: the tsetse fly or the mammalian
host. The nutrient availability and overall environments are different in the host and vector,
requiring the organism to adapt to new biological niches as it transverses through the various life
cycle stages (Figure 1.1).
Upon the bite of an infected tsetse fly, infective metacyclic T. brucei differentiate into
long slender bloodstream forms (BSF) where they proliferate extracellularly in the bloodstream
of the mammalian host. In the glucose rich bloodstream, metabolism is accomplished solely
through glycolysis, as BSF parasites harbor a mitochondrion that is cryptic and not fully
functional (Priest and Hajduk, 1994). The surface of BSF parasites is arrayed with
glycophosphatidylinositol (GPI)-anchored variant surface glycoproteins (VSGs) that aid in
evading the immune response of the host (Horn, 2001). Antigenic variation of the VSGs is
utilized by the parasite, which has a repertoire of > 1000 VSG genes that it can switch
periodically, to avoid death by the adaptive host immune response (Taylor and Rudenko, 2006).
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Figure 1.1 Simplified life cycle of T. brucei.
Long slender parasites proliferate in the mamammalian bloodstream. In preparation for life in the tsetse
fly, BSF parasites differentiate into non-proliferative short stumpy form. Once taken up by the bite of a
tsetse fly, the parasites morph into procyclic form parasites and rapidly divide in the midgut of the fly. To
complete the life cycle, the parasites transition into non-dividing metacyclic forms, residing in the tsetse
fly salivary gland. The parasites begin the life cycle again when they are transmitted back into the
bloodstream of a mammalian host. (Image from: A fatty-acid synthesis mechanism specialized for
parasitism. Lee, SH, Jennifer L. Stephens & Paul T. Englund Nature Reviews Microbiology 5, 287-297
April 2007. Permission granted for use of figure.)

Once BSF parasites reach a high density in the blood, a portion of the cells differentiate
into stumpy form parasites in preparation for the bite of a tsetse fly (Vickerman, 1985, 1965).
The mechanisms controlling the differentiation of BSF to stumpy form parasites are not clearly
understood. Experimentally it has been determined, however, that long slender forms produce a
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stumpy induction factor (SIF) to signal the switch. The identity and mechanism of SIF is
currently unknown (MacGregor and Matthews, 2010).
As BSFs transition to stumpy forms many changes occur in the biology of the parasite.
Stumpy forms are non-proliferative, cell cycle arrested, and have a more active mitochondrion to
prepare them for the low glucose environment that they will soon encounter in the fly (Bass and
Wang, 1991). Stumpy forms are arrested in the G1 stage of the cell cycle, making certain that
changes that occur during transmission into the tsetse fly are coordinated with the resumption of
the cell cycle (Ziegelbauer et al., 1990). The protein surface coat on the stumpy form remains
the same as that of the long slender form, VSG, and is shed and replaced only after taking up
residence in the tsetse fly (Matthews, 2005).
After a fly consumes a blood meal from an infected host, the stumpy form parasites
transition to procyclic forms (PF) in the midgut of the fly. A heterogeneous population of
trypanosomes consisting of BSFs and stumpy forms is consumed in the initial blood meal.
Stumpy form parasites are able to survive the stresses in the harsh environment of the tsetse fly,
while slender BSFs are not (Nolan et al., 2000). Short stumpy forms have developed
mechanisms to adapt to the abrupt environmental, nutrient and temperature changes. Until 2009,
the trigger that cued stumpy forms to switch to PFs remained elusive. However, it is now known
that stumpy forms express a family of proteins, proteins associated with differentiation (PAD),
that can sense the drop in temperature from the mammal (37°C) to the tsetse fly (20°C) which
triggers the switch to the procyclic form parasite (Dean et al., 2009).
PFs rapidly divide in the tsetse fly gut displaying gross biological differences, including
mitochondrial development and organelle positioning, compared to BSFs and short stumpy
forms. These differences allow for survival in the glucose deplete environment of the tsetse fly.
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To this end, PF parasites exhibit an active mitchodrion with components required for a functional
Krebs cycle and electron transport chain. This elaboration of metabolic pathways permits PFs to
metabolize amino acids, rather than solely glucose, for ATP production (Priest and Hadjuk,
1994).
During differentiation between stumpy forms and PFs, the VSG surface coat is replaced
by new set of surface proteins called procyclins (Roditi and Clayton, 1999). Procyclins, like
VSGs, are GPI anchored (Roditi et al., 1989). These surface proteins are characterized by their
internal repeat motifs which consist of either repeats of glutamic acid-proline called EP, or
repeats of 6 peptides (gly-pro-glu-glu-thr) termed GPEET (Roditi and Clayton, 1999). After PFs
have sufficiently proliferated in the midgut, a portion of the parasites move to the salivary gland
where they differentiate into the proliferative epimastigote form and attach to the salivary gland
wall through changes made in their flagellar structure (Van Den Abbeele et al., 1999; Sharma et
al., 2009). In preparation for infection of mammals, the parasites mature through one last
developmental stage, the metacylic form, in which the surface coat is switched back to VSG and
division is arrested (Van Den Abbeele et al., 1999). After differentiating to metacyclics, the
parasites are prepared to infect a new host and repeat the life cycle. The process for PF parasites
to progress to the metacyclic stage and become competent to infect a mammal takes ~3-5 weeks
(Fenn and Matthews, 2007).

II. CELL STRUCTURE AND BIOLOGY
Trypanosomes are single celled protozoa classified as kinetoplastids. T. brucei, are
microscopic and dependent on life cycle stage, range in size from 12-35 µM (Rotureau et al.,
2011). The cell body of the parasite is organized in such a fashion that as it progresses through
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the life cycle, single copy organelles of the cell (flagellar pocket, flagellum, kinetoplast,
mitochondrion, and nucleus) can divide and differentiate efficiently (Matthews, 2005). An
elongated and highly polarized microtubule cytoskeleton defines the shape of the parasite
(Robinson et al., 1995). (Fig.1.2)
Golgi

Nucleus

ER

Flagellar	
  Pocket

Kinetoplast Endosomes

Flagellum

Lysosome Mitochondrion

Surface	
  Protein	
  Coat

Glycosomes

Figure 1.2 Schematic representation of the cellular organization of T. brucei.
T. brucei contain typical organelles found in eukaryotic cells. To note, T. brucei also contain unique
organelles including the kinetoplast, flagellar pocket and glycosomes. (Adapted from: Overath, P. and
Engstler, M. 2004. Endocytosis, membrane recycling and sorting of GPI-anchored proteins:
Trypanosoma brucei as a model system. Molecular Microbiology 53: 735-744. Permission granted for
use of figure.)

A single flagellum arises out of the basal body near the posterior end of the cell and
extends a short distance past the length of the cell (Ralston et al., 2009). T. brucei rely on their
flagellum for motility, attachment to the tsetse fly salivary gland prior to transmission, and for a
wide array of other cellular functions including proper cell division. The flagellum consists of a
conventional axonemal structure (9+2 arrangement of microtubules) plus an associated
paraflagellar rod, which contributes further to the motility of the organism (Vickerman, 1962;
6

Bastin and Gull, 1999). This organelle remains in close proximity to the cell via the flagellar
attachment zone (FAZ), which includes a group of cytoskeletal and membranous attachments
(Portman and Gull, 2010). Also important in the flagellar structure is the flagellar pocket, an
invagination formed at the site where the flagellum emerges from the basal body (Ralston et al.,
2009). The flagellar pocket is the only site of endocytosis or exocytosis for T. brucei (Overath
and Engstler, 2004; Morgan et al., 2002).
All kinetoplastida contain a single mitochondrion. The mitochondrion function and
development in T. brucei varies greatly, dependent on life cycle stage (Van Hellemond et al.,
2005). T. brucei harbor a single elongated mitochondrion that runs from the posterior to the
anterior of the cell. In BSF parasites the mitochondria is a simple tubular structure containing no
cristae, as the parasite relies solely on glycolysis for ATP production (Opperdoes and Borst,
1977). PF parasites, however, have an active mitochondrion with components of the Krebs cycle
and the electron transport chain being present and active to facilitate ATP production (Besterio et
al., 2002).
Located in the mitochondrion of the cell is an organelle known as the kinetoplast. The
kinetoplast is composed of the mitochondrial DNA (kDNA), arranged as a network of
concatenated circles (Klingbeil et al., 2001). The kDNA consists of thousands of minicircles
(0.5-10kb) and only 40-50 maxicircles (20-40kb) that encode mitochondrial gene products such
as rRNAs and respiratory chain subunits (Van Hellemond et al., 2005). The expression of
mitochondrial genes is unconventional, though, in that before the mRNA is competent to express
a functional protein, it must be edited through the activity of minicircle encoded guide RNAs
(Madison et al., 2002).
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The position of the kinetoplast changes as the cell moves through the various life cycle
stages. In BSF parasites, the kinetoplast is close to the posterior end of the cell whereas the
kinetoplast is located midway between the cell nucleus and posterior end in PF parasites
(Matthews, 2005). The repositioning of the kinetoplast is the most obvious morphological
difference between the different life cycle stages of the parasites. The exact cellular mechanism
of this repositioning is not clearly understood, but the correct positioning must occur for proper
cell division in each life cycle (Matthews et al., 1995).
Another unique aspect of trypanosome cell structure is the sequestration of select
metabolic enzymes in small organelles called glycosomes (Opperdoes and Borst, 1977). These
organelles are abundant in the cell and share some similarity in content, structure, and
biosynthesis to peroxisomes from other organisms (Parsons, 2004). The proteins housed in these
small membrane bound organelles vary throughout the life cycle of the parasite as nutrient
availability changes (Michels et al., 2006).

Glycosomes
Opperdoes and Borst (1977) first discovered glycosomes in T. brucei, revealing in BSF
parasites these organelles housed nine glycolytic enzymes. The original discovery of these
microbodies by Opperdoes et al. led to the name glycosome, to designate a unique organelle in
the parasite (Parsons, 2004). Similar to peroxisomes in other organisms, glycosomes are bound
by a single phospholipid bilayer and contain no DNA. Early studies revealed that the contents
found in glycosomes were similar to those of peroxisomes in other organisms (Opperdoes,
1984). The hallmark peroxisomal enzyme found in other organisms is catalase, and only a few
of the trypanosomatid species contain this enzyme in their glycosomes (Soares and De Souza,
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1988). Glycosomal matrix and membrane proteins are imported post-translationally by a family
of proteins called peroxins (PEX) (Moyersoen et al., 2004). Several peroxins have been
identified in trypanosomes and are similar in sequence to yeast and human PEX proteins (Lorenz
et al., 1998; Furuya et al., 2002; Guerra-Giraldez et al., 2002), .
Biogenesis of glycosomes in T. brucei is similar to the biogenesis of peroxisomes in
other organisms (Moyersoen et al., 2004). As the parasites encounter highly different
environmental conditions in each life cycle stage, the contents of the glycosomes must change to
adapt to metabolic needs. When conditions change, as in the switch from the vector to the host,
the contents in old glycosomes are no longer useful. Therefore, these glycosomes are degraded
and replaced. This turnover process is a special form of autophagy, called pexophagy
(Monastryska and Klionsky, 2006). Pexophagy is an important process for the cell during
differentiation from BSFs to short stumpy forms. The process is more robust and rapid as the
parasites transition from stumpy forms to PFs, reflective of a major change in environment
(Herman et al., 2008). This remodeling event ensures that the metabolic contents of the
glycosome are most optimally suited for the current environmental conditions.
Function of Glycosomes in BSF Parasites
Glycosomes of BSF parasites contain ~90% glycolytic enzymes, while the percentage of
glycolytic enzymes in PF glycosomes is only 40-50% (Michels et al., 2006). One main
postulation for the compartmentalization of glycolytic enzymes in BSF is the inability of T.
brucei hexokinase (HK) and phosphofructokinase (PFK) to be inhibited by their products
(Nwagwa and Opperdoes 1982; Cronin and Tipton, 1985; Lopez et al., 2002). Most HKs and
PFKs, in other organisms, are tightly regulated by their products, or other metabolites, to prevent
accumulation of glycolytic intermediates, which can be lethal to the cell (Haanstra et al., 2008).
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Computer modeling to determine how glycolytic flux would be affected in BSF cells lacking
compartmentalization of glycolytic enzymes revealed that steady-state glycolytic flux would not
be altered, but that there would be a toxic accumulation of hexose-phosphates in the presence of
glucose (Bakker et al., 1997). The cell, therefore compartmentalizes the glycolytic enzymes to
prevent this toxic accumulation (and coincident depletion of cellular ATP) and to control the
enzyme activity of HK and PFK (Bakker et al., 2000). The conclusion from this study and other
studies reveal that glycosomes are essential for survival of BSF parasites (Guerra-Giraldez et al.,
2002; Furuya et al., 2002).
The first seven enzymes of glycolysis are housed in BSF glycosomes to accomplish the
conversion of glucose to 3-phosphoglycerate. The remaining steps of the pathway are
accomplished in the cytosol (Opperdoes and Borst, 1977). Consumption and production of ATP
and NADP by glycolysis are balanced within the glycosome and net ATP is produced in the
cytosol of the cell, from the overall conversion of glucose to pyruvate (Opperdoes, 1987;
Hammond et al, 1985; Hammond and Bowman, 1980).
Not only are glyocomes essential for BSF survival, correct localization of enzymes to this
compartment is vital. Several studies have revealed that mislocalization of glycolytic enzymes is
detrimental to the parasite (Blattner et al., 1998). One glycolytic enzyme, phosphoglycerate
kinase (PGK) has two major isozymes, one that is expressed in the BSF (PGKg) which localizes
to the glycosome, and one that is mainly expressed in PF (PGKc) which resides in the cytosol.
BSF parasites were rapidly killed when PGKg lacking a glycosomal targeting signal or PGKc
were expressed. These studies, among others, reveal that glycosomal compartmentalization of
certain enzymes are necessary for survival of the cell (Blattner et al., 1998 and Helfert et al.,
2001).
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Function of Glycosomes in PF Parasites
PF parasites, unlike BSF, do not live in a glucose rich environment, but rather proline and
threonine are the main carbon sources available in the insect vector. The cells do, however,
prefer glucose as their main carbon source if it is available (Lamour et al., 2005). In vitro studies
reveal that in glucose depleted media, PF parasites increase the rate (up to 6-fold) of proline
consumption in the mitochondria for ATP production (Lamour et al., 2005).
Growth rates of PF in glucose deplete media are not impacted by the absence of glucose.
This observation led to the conclusion that glycolysis is not essential in PF parasites, and in turn
compartmentalization of glycolytic enzymes is dispensable (Lamour et al., 2005). In continued
experiments, RNAi of PEX14, an essential protein for glycosome formation, was only lethal to
PFs in the presence of glucose, which further confirmed that glycosomes are essential for PF
survival only in the presence of glucose (Furuya et al., 2002).
Unlike BSF glycosomes which house mostly glycolytic enzymes, glycosomes in PF
parasites contain enzymes important in other metabolic pathways including the pentosephosphate pathway, purine salvage, β oxidation of fatty acids and biosynthetic pathways for
pyrimidines, ether-lipids and squalenes (Michels et al., 2006).

III. GLYCOLYSIS IN T. BRUCEI
BSF parasites rely solely on glycolysis for ATP production, whereas, PF parasites utilize
the breakdown of proline and threonine to generate ATP. The glycolytic pathway, however,
does play a role in PF biology, as RNAi of glycolytic enzymes triggers a change in surface
molecule expression (Morris et al., 2002). Also, rapid inhibition of glycolytic enzymes can be
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lethal to PF parasites (Morris et al., 2002; Drew et al., 2003). Therefore, glycolysis is an
essential metabolic pathway in BSF and PF T. brucei.

Hexokinase
Hexokinase (EC 2.7.1.1), the first enzyme in the glycolytic pathway, catalyzes the
transfer of the γ phosphoryl group from ATP to glucose to yield glucose-6-phosphate and ADP.
Although hexokinase is found in most living organisms, the enzyme is divergent across species
with ~34% of the amino acid residues generally conserved in all members of the hexokinase
family. This strong conservation points to the biological relevance of these residues (Kuser et
al., 2000). Many organisms express more than one hexokinase and maintain pools of
hexokinase containing several isoenzymes of different molecular mass and kinetic activity
(Cardenas et al., 1998).
Sacchromyces cerevisiae expresses two hexokinase isoenzymes, PI and PII, which
display 76% amino acid similarity (Kopetzki et al, 1985; Frohlich et al., 1985). The crystal
structure of PII, similar to the structure of many other hexokinases, revealed that the molecule is
distinctly folded into two domains: the large and small domains. The two domains are separated
by a deep cleft where the active site residues are found. Many of the binding site residues in the
cleft are strongly conserved across species (Kuser et al., 2000).

Catalytic base of hexokinase
The catalytic base of yeast HxkII has been identified as aspartic acid 211 (Asp 211) through
tertiary structure determination and experimentation (Anderson et al, 1978.; Bennet and Steitz,
1980). The residue promotes the nucleophilic attack of glucose’s 6-hydroxyl group on the γ-
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phosphate of ATP followed by the transfer of γ-phosphate group to glucose (Jones et al., 1991).
Asp 211 has also been determined to play an important role in glucose binding by hydrogenbonding to OH groups of the sugar. Catalytic activity is lost when Asp 211 is substituted with
another amino acid residue, however, high-affinity sugar binding is retained (Kraakman, et al.,
1999). The catalytic aspartic acid residue is conserved in other hexokinases including human
pancreatic β-cell glucokinase (Asp 205) (Charles et al., 1994; Gidh-Jain et al., 1993) and
Trypanosoma brucei hexokinase 1 (Asp 214) (Morris et al., 2006) .

T. brucei Hexokinase 1 and Hexokinase 2
T. brucei expresses two hexokinases, TbHK1 and TbHK2, which are 98% identical at the
amino acid level, with differences found in the C-terminal end of the proteins (Morris et al.,
2006). TbHK1 and TbHK2 are arranged in tandem on chromosome 10, are both expressed in
BSF and PF parasites (Berriman et al., 2005; Colasante et al., 2006). RNAi and knockout
experiments revealed that TbHK1 and TbHK2 are important for both life cycle stages of the
parasite. Both HKs are essential to BSF parasites, while PFs with a TbHK2 double allele
knockout are viable, though distinct morphological characteristics were noted (Chambers et al.,
2008; Albert et al., 2005; Morris et al., 2006). Current unpublished work suggests that TbHK2
may play a role in glucose sensing in BSF as evidenced by its localization to the flagellum (Joice
and Lyda, unpublished observation). To date, PF TbHK1 double allele knockouts have not been
successfully generated (M.Morris, unpublished observation). The essentiality of the TbHKs in
BSF parasites and their small percentage of similarity to human glucokinase (~30% similar),
make them prime drug target candidates.
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A	
  crystal	
  structure	
  has	
  not	
  been	
  solved	
  for	
  either	
  T.	
  brucei	
  hexokinase,	
  however,	
  
both	
  proteins	
  have	
  been	
  modeled	
  on	
  yeast	
  PII	
  (Morris	
  et	
  al.,	
  2006).	
  	
  	
  The	
  modeling	
  revealed	
  
that	
  the	
  TbHKs,	
  similar	
  to	
  yeast	
  HKs,	
  are	
  composed	
  of	
  two	
  domains	
  separated	
  by	
  a	
  deep	
  
cleft	
  containing	
  the	
  active	
  site	
  (See	
  Figure	
  1.3),	
  and	
  differences	
  between	
  the	
  two	
  almost	
  
identical	
  enzymes	
  lie	
  within	
  the	
  cleft.	
  	
  Several	
  important	
  active-‐site	
  residues	
  are	
  located	
  in	
  
this	
  cleft	
  along	
  with	
  the	
  amino	
  acids	
  responsible	
  for	
  binding	
  glucose	
  (Morris	
  et	
  al.,	
  2006).	
  	
  
Additionally,	
  the	
  catalytic	
  base	
  is	
  located	
  in	
  the	
  cleft	
  (Kuser	
  et	
  al.,	
  2000).	
  	
  Modeling	
  also	
  
revealed	
  that	
  the	
  unique	
  C-‐terminal	
  peptide	
  sequence	
  found	
  in	
  TbHK2	
  may	
  not	
  allow	
  for	
  
conformational	
  changes	
  needed	
  for	
  catalytic	
  activity,	
  or	
  may	
  change	
  the	
  position	
  of	
  the	
  
catalytic	
  base	
  and	
  prevent	
  activity	
  (Morris	
  et	
  al.,	
  2006).
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Figure 1.3 T. brucei hexokinase modeled on yeast hexokinase II.
DS-Modeler- generated structure of T. brucei hexokinase. The protein is comprised of a large domain
and small domain with a deep cleft containing catalytic residues between the two domains. Catalytic
residue, D214, is highlighted. The N-terminal signal structures remain unstructured. (Image adapted
from: Morris, M. et al. 2006. Activity of a Second Trypanosoma brucei hexokinase is controlled by an
18-Amino-Acid C-Terminal Tail. Eukaryotic Cell 5: 2014-2023. Permission granted for use of figure.)
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Characterization of TbHKs
Initial characterization of T. brucei hexokinase (TbHK) revealed that unlike most other
eukaryotic HKs it is not regulated by Glucose-6-phosphate or ADP (Misset et al., 1986).
Another early observation found that TbHK can use a myriad of substrates as its phosphoryl
donor including ITP, UTP, CTP, GTP or ATP (Nwagwu and Opperdoes, 1982). Early research
also indicated instead of existing as a monomer or dimer in the cell, TbHKs exist as multimers,
containing up to six subunits (Misset et al., 1986).
Continued characterization of the enzymes revealed that the TbHKs localize to the
glycosome, which is not suprising in that they both contain peroxisomal targeting sequences
(PTS) at the N-terminal end of the protein. Recent studies suggest that TbHK2 may also localize
to the flagellum (Coley and Lyda, unpublished results). Of note, rTbHK2 lacks detectable HK
activity, while rTbHK1 does display hexokinase activity (Morris et al., 2006). To this end, it is
speculated that native HK activity is obtained from a mixture of TbHK1 and TbHK2 monomers
because the molecular mass of the protein from which native HK activity was obtained was
reflective of a hexameric oligomer (Morris et al., 2006). The exact composition of the hexamer
in its native state, however, is not currently known.

Regulation of Hexokinase Activity
As mentioned previously, TbHKs are unlike most eukaryotic hexokinases that are
regulated via feedback inhibition by their products. Regulation of TbHKs is not accomplished in
a conventional manner, but rather through non-conventional ways such as the oligomerization
state of the enzyme or inhibition by fatty acids found in the glycosome (Chambers et al., 2008;
Morris et al., 2006).
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IV. GENE EXPRESSION
In order for a cell to survive under changing conditions, RNA is continually transcribed
to carry on basic cell functions such as reproduction, growth, repair and regulation of
metabolism. Most organisms control gene expression at the level of transcription initiation.
However, there are other control points that cells often employ to regulate transcription including
RNA stability and transport, RNA processing and translation. T. brucei regulate almost all gene
expression post-transcriptionally, due to the polycistronic arrangment of the genome (Clayton,
2002).

Polycistronic Transcription
The genome of T. brucei is 26 Mb and consists of 11 chromosomes coding for ~9,000
genes (Berriman et al., 2005). The annotation of the T. brucei genome in 2005 confirmed that
protein-coding genes are arranged in large polycistronic units, displaying a unique arrangement
of gene structure for a eukaryotic parasite (Berriman et al., 2005). Transcription, therefore, is
accomplished in a polycistronic fashion with RNA Polymerase II transcribing up to several
hundred contiguous genes (50-200kb) from one polycistron. Unlike operons in bacteria that
encode functionally related genes, genes that are co-transcribed in T. brucei are not necessarily
functionally related (Haile and Papadopoulou, 2007).
The entire genome contains ~200 total bi-directional polycistronic units (Nilsson et al.,
2010). Genes are transcribed in one direction (from the same strand) within a polycistronic unit;
however, neighboring units can display convergent or divergent transcription (Siegel et al.,
2009). The region between two polycistronic units is called a strand switch region (SSR). In
Leishmania major, a kinetoplast sharing 75% similarity in gene arrangement with T. brucei, the
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SSRs have been shown to be initiation or termination sites for transcription with transcription
starting between two divergent SSRs and terminating between convergent SSRs of polycistronic
units (Martinez-Calvillo et al., 2003). It is thus hypothesized that T. brucei transcription start
sites are also located at divergent SSRs (Siegel et al., 2009). Further, recent data provides
evidence that the chromatin structure at the SSRs plays a role in RNA polymerase II
transcription initiation (Siegel et al., 2009).

Figure 1.4 Diagram of Transcription/mRNA Maturation in T. brucei
T. brucei genes are arranged in bi-directional polycistronic units with transcription of up to several
hundred genes occurring from one unit. Strand switch regions are located at divergent transcription sites.
After transcription, the RNA is processed in a coupled trans-splicing/polyadenylation reaction to generate
mature mRNA ready for translation. (Figure	
  adapted	
  from:	
  Haile,	
  S.,	
  and	
  Papadopoulou,	
  B..	
  	
  
Developmental	
  regulation	
  of	
  gene	
  expression	
  in	
  trypanosomatid	
  parasitic	
  protozoa.	
  	
  Current	
  
Opinion	
  in	
  Microbiology.	
  	
  2007;	
  10:	
  1-‐9.	
  	
  Permission	
  granted	
  for	
  use	
  of	
  figure.)

One other proposed mechanism involved in transcriptional initiation in kinetoplasts is the
presence of a modified thymine, called Base J (Bernards et al., 1984). This modified base was
first discovered in the telomeric regions of expression sites of silenced VSGs in BSF parsites.
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Base J is present in nuclear DNA specifically in inactive VSG expression sites. For this reason,
it was initially thought that Base J played a role in gene silencing, however, studies have
revealed that this is most likely not the role of Base J (Cross et al., 2002). Current data suggests
that Base J is involved in some type of telomeric function, its exact role, though is yet to be
discovered (Borst and Sabatini, 2008).
The polycistronic nature of transcription implies that gene expression is not regulated at
the level of transcription initiation in T. brucei , but instead is accomplished almost exclusively
in a post-transcriptional manner. To date only one RNA Polymerase II promoter has been
identified and characterized from T. brucei. This promoter is responsible for driving expression
of the genes for the spliced leader (SL) precursor RNA. Uncharacteristic of eukaryotic
promoters, this promoter does not contain TATA or CCAAT boxes (Bayele, 2009).
Other promoters have also been identified specifically for genes encoding the surface
proteins of both procyclic form (PARP) and bloodstream form (VSG) parasites (Clayton et al.,
1990; Gottesdiener et al., 1991). Notably, these genes are transcribed by RNA polymerase I,
which is usually responsible for transcribing ribosomal RNA genes in other organisms. With the
exception of the few promoters identified, DNA sequences and proteins involved in initiation
and termination of transcription are not well understood in T. brucei (Martinez-Calvillo et al.,
2010). The lack of conventional RNA Polymerase II promoters and the mechanism of
polycistronic transcription together suggest that transcription is primarily constitutive and gene
levels are regulated following transcription. Indeed, the experimental data acquired to date
supports this claim, with elements in the 3’UTRs of genes playing a central role in regulation
(Hehl et al., 1994; Berberof et al., 1995; Hotz et al., 1995; Furger et al., 1997; Vassella et al.,
2000).
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Processing of mRNA
mRNA processing of individual genes occurs after initial transcription of the long array
of genes from each polycistronic unit. mRNA processing in T. brucei is a coupled process
entailing a 5’ and 3’ modification for the mRNA of each protein-coding gene. The first
processing reaction is a trans-splicing event in which a conserved 39nt SL sequence is added to
the 5’ end of each protein-encoding RNA (Sutton and Boothroyd, 1986) providing a cap for the
mRNA. Bioinformatic tools have been used to predict splice sites, which are U-rich
polypyrimidine tracts that precede AG acceptor sites (Clayton, 2002). Recently, these sequences
were confirmed experimentally in work published by Nilsson et al. (2010) in which high
throughput sequencing was used to identify splice sites for almost all of the protein coding genes
in T. brucei. In these experiments, 2500 alternative splice sites were also identified. The
alternative splice sites identified are specific to one of the life cycle stages, revealing that
alternative splicing may be a means of regulation for the parasite.
Addition of the SL to the 5’ end of an mRNA is coupled to 3’ polyadenylation. This is a
coupled reaction, meaning the splice site for a particular gene influences the choice of the
polyadenylation site for the gene directly upstream (LeBowitz et al., 1993). Unlike higher
eukaryotes, there is no conserved polyadenylation signal sequence in T. brucei, therefore
prediction of polyadenylation sites can only be estimated by distance from the downstream
trans-splicing event (Clayton, 2002). In the past year, however, polyadenylation sites for almost
6,000 T. brucei genes have been identified using RNA-seq technology (Siegel et al., 2010). The
data from this effort revealed that many genes contain several functional polyadenylation sites.
The importance of multiple polyadenylated species for the same transcript has not yet been
determined.
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Post-transcriptional Regulation
The changing environments that T. brucei encounters during its life requires plasticity in
gene expression so that genes can be expressed at different levels as the environment and
nutrient availability changes. Most of the genes in trypanosomes are initially transcribed at the
same levels from a polycistron (Martinez-Calvillo et al., 2010). The coupled process of premRNA processing suggests that regulation does not occur during this event, as two unrelated
genes that are located in tandem in a polycistron are processed in the same coupled reaction yet
often exhibit distinct expression profiles (Kabani et al., 2009). Further, several genome wide
studies have recently revealed that only a modest number (between 2-10%) of all T. brucei genes
are regulated at the RNA level (Siegel et al., 2009; Brems et al., 2005; Koumandou et al., 2008;
Jensen et al., 2009; Kabani et al., 2009).
Post-transcriptional regulation can occur at several levels in the cell; mRNA stability and
degradation, translational efficiency, and protein processing, modification and stability (Haile
and Papadopoulou, 2007). These post-transcriptional mechanisms of regulation can affect
splicing, transport, stability, localization and translation of mRNAs (Ouellette and
Papadopoulou, 2009). There are many factors involved in controlling these regulatory processes
including trans-factors such as RNA binding proteins and small RNAs (Clayton and Shapira,
2007). The trans-factors act on cis sequences usually found in the 3’UTRs of mRNAs (Ouellette
and Papadopoulou, 2009).
mRNA Stability and Regulation
One post-transcriptional mechanism through which trypanosomes regulate gene
expression is RNA stability. There are two different ways that mRNA degradation is
accomplished in the cell. An mRNA can be degraded through deadenylation by a poly A
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nuclease followed by degradation in the 3’ à 5’ direction by the exosome (Buttner et al., 2006).
An alternative route used in cells is the removal of the 5’ cap by a protein complex followed by
mRNA degradation in the 5’ à 3’ direction (Parker and Song, 2004). Trypanosomes express the
proteins necessary for both deadenylation and decapping, and both activites have been detected
in trypanosome lysates and deadenylation has been detected in vivo (Milone et al., 2002; Haile et
al., 2003). Sequences involved in stabililizing mRNA have been identified in the 3’UTRs of
several trypanosome genes (Hehl et al., 1994). Regulatory proteins or other trans elements that
bind to the 3’UTRs to confer mRNA stabilization have not yet been identified (Clayton and
Shapira, 2007).

3’UTR Sequences Involved in Regulation
Sequences have been identified in the 3’UTRs of various T. brucei genes that regulate
gene expression by controlling mRNA stability and degradation or by mediating translational
efficiency (Clayton, 2002; Haile and Papadopoulou, 2007).
The most efficient way to identify specific sequences of the 3’UTR involved in
regulation is to use a reporter gene system. After either stable or transient transfection of
reporter gene constructs into pertinent cell lines, mRNA amount, protein expression and mRNA
stability can be quantified (Clayton, 2007). This technique has been used to identify regulatory
regions in many T. brucei 3’UTRs.
The EP procyclin 3’UTR is one of the most well characterized T. brucei UTRs. Hehl et
al. (1994) identified both a 16-mer and a 26-mer that are involved in regulating the expression of
this protein. The 16-mer enhances translation in PFs and the 26-mer is necessary for the
instability of EP procyclin mRNAs in BSFs. Though these are two of the most well
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characterized sequences, many others involved in regulation of gene expression have been
identified in trypanosome 3’UTRs. In some genes, however, it has been challenging to narrow
down specific regions and mechanisms involved in regulation (Clayton and Shapira, 2007).

Coordinated gene expression
Several recent publications examining genomic analysis during different life cycle stages of the
parasite have revealed that post-transcriptional regulation is accomplished in a coordinated
fashion (Kabani et al., 2009; Jensen et al., 2009; Queiroz et al., 2009). These studies revealed
clusters of coordinated gene expression, with many of the clusters containing genes with a
variety of functions; however, some of the genes contained within the cluster were functionally
related. It is postulated that there may be proteins that recognize a group of mRNAs containing
the same sequences in their 3’UTRs, conferring stability on the group of mRNAs in a
coordinated way (Ouellete and Papadopoulou, 2009). The set of mRNAs regulated together is
referred to as a regulon. The complete and detailed mechanisms of coordinated regulation and
cellular components involved are not yet clearly understood. Further characterization of the
3’UTRs of the genes found in these regulons may reveal sequences that are involved in global
regulation of gene expression in T. brucei.
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CHAPTER TWO
DIFFERENTIAL POLYADENYLATION INFLUENCES GENE EXPRESSION IN THE
AFRICAN TRYPANOSOME IN RESPONSE TO ENVIRONMENTAL CUES
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ABSTRACT
Cellular responses to environmental changes include altered gene expression of metabolic
genes. In Trypanosoma brucei, regulatory elements in the 3’UTRs dictate transcript abundance
and protein expression. Through deep sequencing, multiple transcripts generated by differential
polyadenylation have been identified for most genes. Here, we have described how abundance
and expression of seven different transcripts for T. brucei hexokinase 1 (TbHK1) are influenced
by polyadenylation site in a carbon source-dependent fashion. Under standard growth
conditions, relative expression of the TbHK1 3’UTR lengths was similar in procyclic form and
bloodstream form parasite, though overall expression was higher in the bloodstream form. Of
the seven tested, steady-state abundance of transcripts bearing one 3’UTR (1339 nt) was
increased more than 9-fold in the presence of glucose, and two (1352 nt and 1086 nt) were
reduced by more than 10-fold. Translation for all lengths, as measured in a chloramphenicol
acetyl transferase reporter assay, was either down-regulated or unchanged by glucose. TbHK1
expression was also dynamic as a result of growth in glycerol-based media, with the steady-state
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levels of two transcripts (bearing either the 1331 nt or 1034 nt 3’UTR) increased more than 20fold while two (1352 nt and 1086 nt) were decreased more than 6-fold. Translation from the
transcript bearing the 1331 nt 3’UTR was also increased ~2-fold, while other 3’UTRs either had
no impact or attenuated expression in response to glycerol. Notably, steady-state transcript
levels of the single polyadenylated TbHK2 species also responded to carbon source, with a ~3fold increase in the presence of glucose. Translation of TbHK2 was nearly undetectable in the
absence of glucose or glycerol, but similar was expressed at similar levels in the presence of
either carbon source.
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INTRODUCTION
Organisms that occupy multiple biological niches must metabolically adapt to different
environments. Trypanosoma brucei, the protozoan parasite that is the causative agent of African
sleeping sickness, alternates between a mammalian host and an insect vector. As they move
from the mammalian bloodstream to the tsetse gut and migrate to the salivary glands (through
tissues and the hemocoel/plasma, a migration that is poorly understood), the parasites are
exposed to a variety of environmental cues. These include proteases and pH changes in the
insect gut, fluctuating temperatures (the fly is a poikilotherm, so nighttime temperatures may be
significantly less than day), and exposure to different small molecules, both as the bloodmeal is
digested by the fly and during migration through fly tissues.
For a small molecule to serve as an effective “marker” for a particular environment, its
availability must change from one niche to another. Glucose is an example of such a molecule.
Short stumpy form parasites ingested by a feeding tsetse fly experience a rapid drop in glucose
concentration, with the sugar in the blood nearly depleted in ~15 minutes (Vickerman, 1985).
BSF parasites may also encounter changes in glucose concentrations. Both cerebrospinal fluid
and blood glucose concentrations increase in febrile children (Kirviranta et al., 1995) (fever is
frequently associated with trypanosomiasis), while mice infected with T. rhodesiense have
decreased serum glucose (Moon et al., 1968).
In vitro, manipulation of glucose levels trigger changes in gene expression, supporting
the hypothesis that the sugar may act as a key player in environmental sensing. For example,
GPEET procyclin expression is regulated by mitochondrial enzymes in response to changes in
glucose concentrations in the culture (Vassella et al., 2004). Cultured BSF can be triggered to
express PF parasite characters by removal of glucose from the growth medium, even at 37oC
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(Milne et al., 1998). Last, RNAi silencing of glycolytic genes, including the TbHKs, disrupts the
developmentally coordinated expression of surface molecules in PF parasites, suggesting a
connection between the metabolic pathway and development (Morris et al., 2002).
Because the trypanosome genome is organized with protein coding genes arrayed in units
transcribed into single polycistronic RNAs, post-transcriptional mechanisms serve as key
regulators of gene expression control. Following transcription of the pre-mRNA polycistron,
maturation of individual messages occurs in two coupled reactions, with trans-splicing adding a
small capped RNA (the splice leader, SL) to the 5’ end while cleavage and polyadenylation
provide the maturation of the 3’ end of the gene. As a result of this maturation process, which is
common for all protein coding genes, gene regulation is usually mediated by elements found in
message 3’UTRs. For example, the 3’UTRs of procyclins have been shown to regulate both
mRNA levels and translation (Hotz et al., 1997). Elements involved in post-transciptional
regulation have been identified, including a glucose and glycerol response element in the 3’UTR
of GPEET procyclin (Vassella et al., 2004).
Hexokinase (HK), the first enzyme in glycolysis, catalyzes the phosphorylation of
glucose to form glucose-6-phosphate. T. brucei strain 927 harbors two TbHK genes, TbHK1 and
2, that are encoded in tandem on chromosome 10 (Morris et al., 2002; 2006). Both genes are
expressed in BSF and PF parasites, yielding polypeptides that are 98% identical (Morris et al.,
2006; Colasante et al., 2006). While the putative 5’UTRs and ORFs of the genes are 98.5%
identical at the nucleotide level, the 3’UTRs are dissimilar. One consequence of the differences
in the 3’UTRs is that transcript maturation yields a different number of mature polyadenylated
messages. Seven different polyadenylated TbHK1 transcripts have been identified in a genomewide analysis of transcript splicing and polyadenylation, while only one transcript for TbHK2 has
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been identified (Siegel et al., 2010). The molecular mechanisms behind the generation of the
different species of TbHK1 message are unknown; however, here we present evidence that the
different transcript lengths are maintained at different abundance and have distinct expression
patterns in response to environmental growth conditions. These findings suggest that differential
polyadenylation of mRNA in T. brucei serves as a mechanism for gene regulation in the African
trypanosome.

MATERIALS AND METHODS
Trypanosome growth and transfection - Procyclic form T. brucei 29.13, a 427 strain that
expresses T7 RNA polymerase and the tetracycline repressor, were grown and maintained in
SDM79 (Brun and Shonenberger, 1979) supplemented with 15% fetal bovine serum under
standard growth conditions (29°C, 5% CO2). For experiments performed in low glucose or
glycerol supplemented media, SDM80 (Lamour et al., 2005) was prepared with 9% heatinactivated dialyzed FBS and 1% heat-inactivated non-dialyzed FBS and, where noted, 10mM
glycerol was added to the culture. Transient transfections (1 x 108 cells, 10µg DNA) were
performed in 0.4 cm gapped cuvettes using an ECM 830 Electroporator (Genetronics, Inc., San
Diego, CA). Briefly, cells were pelleted (800 x g, 10 min), washed, and then transferred to a
cuvette with DNA and transfected (1700V, 100µs, 3 pulses, 200ms). Immediately after
transfections cells were resuspended in SDM79, SDM80 or SDM80 supplemented with glycerol
for 24 hours prior to RNA isolation, CAT assay or TbHK assay. (Please note that results of
assays performed in SDM79 (6 mM glucose) yielded results that were essentially identical to
those performed in SDM80 supplemented with glucose.)
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Constructs - For all CAT reporter constructs, pGAPRONE (Furger et al., 1997) harboring a
CAT reporter gene under the control of a procyclin promoter was used as the backbone for
cloning of the respective TbHK 3’UTRs. In short, primers containing a BamHI site in the
forward primer and XbaI site in the reverse primer for cloning were designed to amplify the
varying lengths of authentic TbHK1 UTRs. The preexisting EP1 3’UTR in the parent
pGAPRONE vector was removed by restriction enzyme digest and amplified UTRs were ligated
in its place. All constructs were confirmed by DNA sequencing.

Quantitative Real Time PCR - Steady-state mRNA abundance of constructs bearing the
authentic TbHK1 UTRs was assessed by qRT-PCR using primers specific to the CAT reporter
gene (F CAT: 5’ GCGTGTTACGGTGAAAACCT 3’ and R CAT: 5’ ATCACA
GACGGATGATGAA 3’) which yields a 219 bp PCR product. Actin was used as the reference
gene for all qRT-PCR experiments (F Actin: 5’ GCCACGTATTTCCATCCATC 3’ and R Actin:
5’ CCTGAGCTTCATCACCAACA 3’). For qRT-PCR, a total of 5 x106 PF parasites were
pelleted (800 x g, 10 min), washed in PBS and total RNA isolated (Aurum™ Total RNA Mini
Kit, Bio-Rad, Hercules, CA) followed by DNase treatment on the purification column per the
manufacturers instructions. A one-step qRT-PCR kit (iScript One-Step RT-PCR Kit with SYBR
Green, Bio-Rad, Hercules, CA) was used for cDNA synthesis and amplification. qRT-PCR was
performed on an iCycler iQ System (Bio-Rad, Hercules, CA) and resulting data was analyzed
using the Pfaffl method (Pfaffl, 2001).

CAT Reporter Gene Assays - Chloramphenicol acetyl transferase (CAT) activity was assessed
in lysates from transiently transfected cells in a 96 well plate format using a GENios
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spectrophotometer (Tecan Group Ltd., Switzerland). Twenty-four hours post-transfection, cells
were counted and hypotonically lysed. Assays were performed in 250 µL total volume
containing final concentrations of 100 µM Acetyl-CoA (MP Biomedicals, Solon, OH), 100 µM
chloramphenicol (MP Biomedicals, Solon, OH) and 0.5 µM DTNB (G Biosciences, Maryland
Heights, MO). The assay scores the transfer of the acetyl group to one of the two hydroxyl
groups on chloramphenicol. During this transfer, a thiol is released from the acetyl-CoA which
reacts with 5,5-dithio-bis 2-nitrobenzoic acid (DTNB) to release 2-nitro-5-mercaptobenzoic acid
(TNB), which then is measured by absorbance at 405nm.

Hexokinase Assays - To assess hexokinase activity from PF cells, lysate was prepared as
described (Chambers et al., 2008). Hexokinase activity was measured in triplicate using a
previously described coupled reaction (Morris et al., 2002).

RESULTS
The genome of the African trypanosomes is organized into polycistronic units that are
transcribed into long RNAs that, through RNA maturation, yield functional transcripts. As a
result of this unusual transcription mechanism, regulation of gene expression occurs primarily
post-transcriptionally with 3’UTR sequences serving to regulate gene expression. Recently,
Siegel et al. (Siegel et al., 2010) identified polyadenylation sites for 5,948 T. brucei genes using
high throughput RNA sequencing technology (Siegel et al., 2010). TbHK1 had seven distinct
polyadenylation sites resulting in 3’UTR lengths of 1026, 1034, 1086, 1166, 1331, 1339 and
1352 nt (Fig. 2.1A). TbHK2, however, had only one polyadenylation site, yielding a 3’UTR of
353 nt. The relative abundance of the UTR lengths in PF parasites cultured in standard media
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(SDM 79) was also reported, with 1339 nt being the most abundant (33% of the total) while the
1352 nt and 1166 nt species made up 17% (each) of the total. The remaining four lengths
accounted for the rest, with each having an abundance of 8% (Sigel, 2010).

Figure 2.1 Polyadenylation influences TbHK1 steady state abundance in PF and BSF
parasites.
45

(A) Schematic representation of TbHK1 depicting the location and abundance of polyadenylation sites for the gene
(Siegel, 2010). The thickness of the arrow corresponds to the percentage of the UTR transcript detected in PF cells
maintained in glucose-rich media: 1026, 1034, 1086 and 1331 (8% each), 1166 and 1352 (17%) and 1339 (33%).
Relative abundance of a reporter gene bearing the different TbHK1 3’UTRs in PF (B) and BSF (C). Both cell lines
were transiently transfected with a construct containing the respective UTR length downstream of the CAT reporter
gene. qRT-PCR was used to measure CAT transcript abundance with actin transcript as a reference (Pfaffl, 2001).

TbHK1 transcript abundance in both PF and BSF parasites is dependent on polyadenylation
site. The presence of multiple polyadenylated TbHK1 transcript species, particularly in light of
the single TbHK2 species, suggested that the distinct UTRs might have a role in the regulation of
TbHK1. To study the consequences of the different lengths of UTRs on steady state mRNA
levels, PF and BSF parasites were transiently transfected with an expression vector containing a
CAT reporter gene fused to the TbHK UTRs, followed by analysis of CAT transcript levels by
qRT-PCR using primers to the CAT ORF (Fig. 2.1B and 2.1C).
In both PF and BSF parasites, the shorter UTRs typically yielded the highest relative
abundance (compared to the reference gene actin), with the distribution of the relative transcript
levels being remarkably similar between the two life cycle stages. However, there are notable
exceptions to this trend. Unlike the PF cells, which maintain nearly twice as much 1339 nt
3’UTR transcript as the 8 nt shorter 1331 nt construct, BSF have higher steady-state levels of the
1331 nt 3’UTR than the 1339 nt length.

TbHK1 3’UTRs influence both transcript abundance and gene expression in response to glucose
depletion - The diversity of 3’UTRs associated with the TbHK1 gene led us to consider the
possibility that the process of message maturation, particularly polyadenylation, may be part of a
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response to environmental cues. Using qRT-PCR, the transcript levels of CAT harboring the
TbHK1 3’UTRs were quantified in PF cells that were either maintained in glucose-rich media or
were shifted to low glucose media after transfection of the reporter. In response to glucose,
steady state levels of 1339 nt 3’UTR reporter were increased more than nine-fold (Fig. 2.2A).
Transcripts harboring other TbHK1 3’UTR lengths were less responsive to glucose, with the
1166 nt 3’UTR and 1026 nt 3’UTR in particular demonstrating little change in abundance.
Transcript levels for constructs bearing the 1352 nt and 1086 nt 3’UTR were reduced, with the
former reduced ~10-fold while the latter was reduced to undetectable levels.
To assess the consequences of the 3’UTRs on expression, CAT enzyme activity was
monitored from cell lysate from transfectants. In the absence of glucose, expression from all
constructs was detected, ranging from 3.22-8.5 units of CAT activity (Fig. 2.2B). However,
culturing the transformed parasites in the presence of glucose had a marked impact on CAT
expression. Expression of CAT from constructs harboring the two longest 3’UTRs (1352 and
1339 nt) was undetectable, while expression from other constructs was unaffected by the
presence or absence of glucose (1086 nt, for example).

Glycerol as a carbon source alters TbHK1 transcript abundance and expression in a 3’UTRdependent fashion - Glucose and glycerol have been identified as glycolytic substrates that can
influence gene expression in PF T. brucei. Both compounds regulate GPEET procyclin
expression, for example, through a single element in the 3’UTR (the GRE) (Vassella et al.,
2004). To assess the impact of glycerol on TbHK1 expression and determine if particular 3’UTR
lengths influence the response, both transcript steady state levels and expression were scored in
transiently transfected parasites grown in glycerol using the CAT reporters described above.
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While the over-all fold change in transcript abundance was greater after cells were shifted to
glycerol containing media (as compared to those shifted to glucose (Fig. 2.2A)), there was a
notable conservation of the pattern of transcript abundance. For example, constructs bearing the
1086 nt 3’UTR were once again reduced (as a result of growth in either glucose or glycerol),
while 1034 nt 3’UTR had a greater fold-change in both glucose and glycerol than the 1026 nt
3’UTR constructs (Fig. 2.3A). This trend was true with one dramatic exception – constructs
bearing the 1331 nt 3’UTR were increased more than 30-fold in response to glycerol, while the
1339 nt 3’UTR constructs were unchanged (Fig. 2.3A). This observation contrasts with the
observed relative increase in the 1339 nt 3’UTR construct in response to glucose (Fig. 2.2A).
For the majority of the 3’UTRs, CAT expression was modestly altered as a result of
culturing in the presence of glycerol (Fig. 2.3A). Expression from constructs bearing the 1026,
1034, and 1086 nt UTRs was repressed (1.45-2.7-fold), while the near complete repression of
1166 and 1339 nt 3’UTR-bearing constructs was similar to the loss of expression observed for
the same constructs in response to glucose. Conversely, the expression from the 1331 nt 3’UTR
construct was increased nearly 2-fold, and the 1352 nt 3’UTR was minimally enhanced (1.2fold), though the maintenance of expression of the latter construct is in marked contrast to its
complete repression in the presence of glucose (Fig.2.2B).
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Figure 2.2 Transcript and expression levels of CAT bearing the seven different TbHK1 3’UTR lengths in glucose-rich media.
(A) Transcript levels measured from PF cells cultured in either glucose-rich or deplete media following transient transfection with constructs harboring the
TbHK1 3’UTRs. Fold change was determined using the Pfaffl method with comparisons made between cells cultured in low glucose versus high glucose. A
value equal to one indicates no change in transcript abundance. (B) Expression changes as a result of 3’UTR length. CAT enzyme activity was measured from
lysates of transiently transfected PF cells cultured under glucose-rich or deplete media, with units determined by comparison to standard curve. (Hatched bars+Glc; solid bars –Glc
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Figure 2.3 Growth in glycerol also alters steady state TbHK1 transcript and expression in a 3’UTR-dependent fashion.
(A) Steady state transcript levels or (B) CAT activity from PF cells transiently transfected with reporter constructs followed by growth with (hatched bars) or
without (solid bars) glycerol supplementation of SDM-80.
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Impact of growth conditions on TbHK2 expression and activity – The single 353 nt 3’UTR found
on the TbHK2 transcript also influenced steady state abundance and expression in a nutrientsensitive manner. Growth in the presence of glucose, but not glycerol, yielded a 3.6-fold
increase in steady state transcript abundance. At the level of CAT expression, growth in either
glucose or glycerol yielded similar expression levels, while growth in the absence of either
carbon source led to a loss of detectable CAT activity.

Figure 2.4. TbHK2 3’UTR yields differential expression for cells grown in the presence of
glucose or glycerol.
(A) Steady state transcript levels or (B) CAT activity from PF cells transiently transfected with a reporter
construct harboring the TbHK2 3’UTR followed by growth in the presence of glucose or glycerol. Steady
state transcript levels are relative to transcript abundance in the absence of glucose or glycerol, with all
levels normalized to actin.
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TbHK enzyme activity is dependent on carbon source availability - HK activity in the African
trypanosome is the result of multiple layers of regulation that include mechanisms that regulate
steady-state transcript abundance and expression. Other mechanisms, including post-translational
modification and oligomerization with TbHK2 (Chambers et al., 2008), are likely involved in
regulation of TbHK activity, leading us to consider the impact of carbon source availability on
cellular HK activity. Cells grown in media supplemented with glucose had the lowest TbHK
activity per cell, while parasites grown in media lacking glucose or supplemented with glycerol
had 2.3 and 3.3-fold higher TbHK activity, consistent with the general increase in CAT
expression observed in cells grown under the two conditions (Fig. 2.4).

Figure 2.5 Growth conditions alter TbHK activity from PF lysates.
Trypanosomal lysates prepared by hypotonic lysis of cells grown in media containing the indicated carbon source
for 24 hr were assayed for hexokinase activity as described in Materials and Methods.
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DISCUSSION
Cellular mechanisms for responses to changes in nutrient availability are found in
organisms as diverse as microbes and man. They are responsible for a fundamental process and
include transcriptional, post-transcriptional, translational, and post-translational mechanisms but
are unified in their importance for ensuring continued satisfaction of metabolic needs as
environmental conditions change. Here, we have described how differential polyadenylation
generates mRNA species that bear 3’UTRs that influence both steady-state transcript abundance
and expression in response to environmental growth conditions.
Polyadenylation is critical for generation of the 3’ ends of mRNAs in eukaryotes.
Additionally, it provides a mechanism for influencing transcript maturation, particularly when
intronic polyadenylation sites yield alternatively spliced message. Such a mechanism allows
mammalian cells to generate isoforms of a given protein, and bioinformatic analysis suggests
that ~50% of human genes have multiple polyadenylation signals, with ~20% having at least one
intronic polyadenylation site (Gong et al., 2010; Tian et al., 2007; Tian et al., 2005).
While the TbHK1 gene lacks introns, a similar mechanism may be at work here. This
model is distinct from regulation of gene expression through control of pre-mRNA processing,
which is not anticipated because the genes found in polycistrons in T. brucei are functionally
unrelated and not organized into operon-like clusters (Berriman et al., 2005). Instead, premRNA is matured as described, with the 5’ addition of the SL to the 3’ gene providing
information for cleavage and polyadenylation of the 3’ end of the 5’ gene. Regulation, however,
does occur at the choice of 3’ cleavage sites in response to environmental cues. In eukaryotes,
mRNA polyadenylation typically prevents message degradation, but in some cases can promote
it, leading us to speculate that steady-state transcript abundance could be a reflection of
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preferential degradation of some forms of TbHK1 message – with maintenance of others –
depending on the polyadenylation site (Table 1). This model is transcription-independent, which
is key in the T. brucei system (because of the polycistronic transcription). Alternatively, (or
additionally), maturation may not occur at all sites at equal frequency in response to
environmental cues, leading to an increase in some species over others. In either case,
alternative polyadenylation would likely yield mRNAs that bear different regulatory elements
that then impact transcript stability and expression, depending on environmental cues.
3’UTR
Length (nt)
TbHK1

TbHK2

1026
1034
1086
1166
1331
1339
1352
353

Transcript
Abundance
+Glc
+ Gly
+
+++
+++
++++
+
+
+++
+
++++
+++
+
+++
+

-Glc
+++
+++
+++
+++
+++
+++
+++
-

CAT
Expression
+Glc
+Gly
+++
+
+
+++
+++
+++
+
+
+++
++++
+
+

Table 2.1. Summary of the impact of different TbHK UTR lengths on transcript
abundance and CAT expression.
In agreement with previously published work (Siegel et al., 2010), the 1339 nt 3’UTRbearing TbHK1 transcript was the most abundant message in media supplemented with glucose
(Fig. 2.2A). Interestingly, protein expression was not detected from the same construct when
cells were grown in the presence of glucose. This observation suggests that the transcript is
synthesized and maintained but either lacks a cofactor required for protein synthesis or binds an
inhibitor of protein expression under glucose-replete conditions. The two 3’UTRs with lengths
most similar to the 1339 nt 3’UTR (1331 nt and 1352 nt) were not maintained at the transcript
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level, suggesting that the stabilizing sequence may be removed during maturation of the shorter
transcript (1331 nt) or masked by the longer 1352 nt 3’UTR.
The interesting difference in response to environmental nutrients at both the transcript
and expression levels of transcripts bearing the 1339 nt and 1331 nt 3’UTR suggests that 3’UTR
variants are generated to yield transcripts bearing distinct response elements. The eight
nucleotides (aacacttt) that distinguish the 1339 nt 3’UTR from the 1331 nt species are indeed
over-represented in the genome, suggesting a potential functional bias. With an average 3’UTR
length of 604 nt, one would expect the 8-mer to populate the 5948 genes almost 55 times, but the
sequence is found 111 times in the 3’UTR. This may reflect an artifact of a bias for A/T in the
3’UTR, but the sequence is found in the 3’UTRs of all five glycerol kinase (GK) genes
(Tb09.211.3540, Tb09.211.3550, Tb09.211.3560, Tb09.211.3570, and Tb09.211.3590),
suggesting some regulatory function in response to glycerol. The observation that the constructs
bearing the 1339 nt 3’UTR are suppressed relative to the 1331 construct in the presence of
glycerol suggests that the sequence is a negative regulator. Its presence in the 3’UTRs of the GK
genes may reflect a regulatory mechanism to prevent catastrophic consumption of ATP by the
enzyme in the presence of glycerol.
The 8nt difference between the 1339 nt and 1331 nt 3’UTR length also shared some
sequence homology with the previously identified translation enhancer 16-mer element found in
procyclin 3’UTRs (Hehl, 1994). Predictive m-fold structures particularly to the 3’ end of the two
different UTR’s reveal that the 1339 nt 3’UTR contains a stem-loop structure at the end of the
UTR, whereas the 1331 nt length does not form this structure (Figure 2.6). Interestingly, the 16mer element identified in procyclin also forms a stem-loop structure and is not functional when
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this RNA structure is lacking. Further characterization of this sequence is needed to fully
determine the role that it plays in the regulation of TbHK1 transcript level and expression.
A.

B.

Figure 2.6. m-fold Structure of 1331nt and 1339 nt TbHK1 3’UTRs.
m-fold predicated structure of (A) 1331 nt (B) 1339 TbHK1 3’UTR. Homology shared with the procyclin 16-mer
3’UTR regulatory element (Hehl et al., 1994) is highlighted in red.
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Overall, our study reveals that differential polyadenylation is not stochastic, but rather is
involved in conferring regulation of gene expression of the glycolytic enzyme, TbHK1. The
high number of genes with multiple polyadenylation sites from two recent RNA-seq efforts
(Siegel et al., 2010; Kolev et al., 2010) suggests that the parasite likely employs this mechanism
of regulation for many genes, in order to rapidly and efficiently adapt to gross and subtle
environmental changes.
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CHAPTER 3
GLYCEROL-3-PHOSPHATE ALTERS TRYPANOSOMA BRUCEI HEXOKINASE
ACTIVITY IN RESPONSE TO ENVIRONMENTAL CHANGE
Heidi C. Dodson, Meredith T. Morris, and James C. Morris
Department of Genetics and Biochemistry
Clemson University
Clemson, SC 29634

ABSTRACT:
The African trypanosome, Trypanosoma brucei, compartmentalizes some metabolic
enzymes within peroxisome-like organelles, glycosomes. The amounts, activities, and types of
glycosomal enzymes are modulated coincident with developmental and environmental changes.
Pexophagy, fusion of glycosomes with acidic lysosomes, has been proposed to facilitate this
glycosome remodeling. In vitro, the recombinant glycosomal enzyme T. brucei hexokinase 1
(rTbHK1) was inactivated under acidic conditions. Glycerol-3-phosphate (Gly3P), which is
produced in the glycosome by glycerol kinase, mitigated acid inactivation of rTbHK1 and
parasite lysate-derived TbHK activity. Glycerol-2-phosphate likewise prevented inactivation,
while glycerol did not.
Gly3P influences rTbHK1 activity at pH 6.5 by preventing substrate and product
inhibition by ATP and ADP, respectively. Gly3P protects rTbHK1 from quercetin (QCN)
inhibition at pH 7.4 partially and completely at pH 6.5. However, Gly3P does not alter the

61

interaction of QCN with TbHK1, as the lone Trp (Trp177) was quenched under all conditions
tested. These findings suggest potential novel mechanisms for the regulation of TbHK1,
particularly given the changes in cellular concentrations of Gly3P and the acidification of
glycosomes that can be induced under a variety of parasite growth conditions.
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INTRODUCTION:
Regulation of metabolism is a central response to environmental changes that the parasitic
protozoan Trypanosoma brucei encounters in its lifecycle. Metabolic pathways are adapted for
nutrients available in either the tsetse fly vector or mammalian host. For example, procyclic
form (PF) parasites residing in the tsetse fly metabolize both glucose and amino acids, while
glycolysis is the sole ATP source for bloodstream form (BSF) trypanosomes.
Trypanosomes compartmentalize parts of the glycolytic pathway in an organelle called
the glycosome. These organelles contain the first six or seven enzymes of glucose metabolism as
well as enzymes involved in ether lipid biosynthesis and fatty acid oxidation. In addition, two
enzymes involved in glycerol metabolism, glycerol-3-phosphate dehydrogenase (G3PDH) and
glycerol kinase (GK) are localized to this compartment (Opperdoes and Borst, 1977).
In the glycosome, glucose is initially converted to fructose-1,6-bisphosphate (FBP), a
process that requires the consumption of ATP by both the trypanosome hexokinase (TbHK) and
phosphofructokinase (TbPFK). These two enzymes are unusual in that they are insensitive to
feedback inhibition by their products (Nwagwu and Opperdoes, 1982; Cronin and Tipton, 1985,
1987). One result of compartmentalization is that ATP production and consumption within the
glycosome is balanced, with net ATP only synthesized in the cytosol. It has been suggested by
modeling experiments that compartmentalization prevents the unproductive consumption of the
net ATP (referred to as “turbo-explosion”) by either the TbHKs or TbPFK (Haanstra et al.,
2008). RNA interference (RNAi) studies of genes essential to glycosome biosynthesis support
this observation, as glucose is toxic to PF T. brucei lacking glycosomes, presumably as a result
of inappropriate consumption of cytosolic ATP (Furuya et al., 2002), while RNAi of TbHK in
the glycosome deficient cells is protective (Kessler and Parsons, 2005).
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The “turbo-explosion” model suggests compartmentalization protects the cell from
inappropriate kinase consumption of ATP. Additional layers of TbHK regulation have recently
been identified, including alteration of enzyme activity as a result of changes in the
oligomerization state of the enzyme. Trypanosomes express two 98% identical TbHKs (TbHK1
and TbHK2) that have different biochemical properties, including distinct sensitivity to
pyrophosphate. Changes in oligomer composition can influence in vitro enzyme activity and
sensitivity to pyrophosphate (Chambers et al., 2008). As further evidence of TbHK regulation
mechanisms, TbHK1 can be inhibited by fatty acids that are found within the glycosome (Morris
et al., 2006).
The glycosomal protein repertoire is altered in response to developmental and
environmental changes. For example, as the parasite transits from the short stumpy form (which
is found in the mammalian blood and are preadapted for life in the tsetse fly vector), glycosomes
fuse with lysosomes (Herman et al., 2008). A process similar to pexophagy, which is the
autophagy of peroxisomes in response to metabolic changes found in yeast, has been implicated
in the turnover of glycosomal components. Here we demonstrate that TbHK1, which is sensitive
to pH as a result of substrate and product inhibition, is protected by glycerol-3-phosphate
(Gly3P), a metabolite that accumulates under some growth conditions. These observations
suggest a novel means of regulation of an essential activity in the African trypanosome.
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MATERIALS AND METHODS
Reagents - ATP and ADP were purchased from Calbiochem (San Diego, CA). To confirm
purity (reported by the manufacturer to be >95%), both compounds were resolved by HPLC
(Waters, Milford, MA) using an isocratic buffering system (100 mM KH2PO4 , pH 6.5, 1.2%
methanol) on a Symmetry C18 (5µm, 4.6 x 150 mm) column at a flow rate of 1.0 ml/min.
Compounds were detected at 259 nm on a dual UV detector and analyzed by Breeze 3.2V
software. Antisera to T. brucei glycerol kinase (TbGK) (1:100,000), T. brucei hexokinase
(TbHK, which detects both TbHK1 and TbHK2) (1:100,000), T. brucei triosephosphate
isomerase (TbTIM) (1:3,500), and T. brucei enolase (TbENO) (1:10,000) were the generous gift
of Dr. Paul Michels (Laboratory of Biochemistry, Université catholique de Louvain). Antiserum
to T. brucei PEX11 (TbPEX11) (1:4,000) was the gift of Dr. Christine Clayton (Center for
Molecular Biology Heidelberg, University of Heidelberg). Quercetin (3,3’,4’,5,7pentahydroxyflavone) was purchased from Spectrum Chemical Manufacturing Corporation
(Gardena, CA).

Cell Culture and Transformation - Both procyclic and bloodstream form (PF and BSF)
Trypanosoma brucei brucei strain 427 (29-13 and 90-13, respectively) were used in the cellular
studies. PF parasites were grown in SDM 79 (Wirtz et al., 1999; Wang et al., 2000) to a density
of 1x107 cells/ml, collected by centrifugation (10 min, 3000 x g), and stored at -20°C until use.
To lyse cell pellets, the parasites were thawed, washed, and resuspended in ddH20 to a final
concentration of 1x108 cells/ml. Lysis buffer (0.1% Triton X-100, 50 mM TEA, pH 7.4, 1 mM
PMSF, 20mg/mL leupeptin, 100mg/mL TLCK) was added to the mixture to minimize protein
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degradation upon lysis. BSF parasites were treated similarly, with cell pellets frozen initially at a
concentration of 1x106 cells/ml.

Recombinant Enzyme and Assay Conditions- For purification of rTbHK1, a previously described
protocol (Morris et al., 2006) was modified to increase yield. Briefly, a starter culture of E. coli
M15(pREP) harboring pQE30 (Qiagen, Valencia, CA) with TbHK1 cloned in frame of a 6-His
tagging sequence was grown in ECPM1 (Wigelsworth et al., 2004). The starter culture was used
to inoculate a 5 L culture in a bioreactor (Biostat B, B. Braun Biotech International, Allentown,
PA) at 37oC supplemented with O2. The culture was induced with 0.8 mM IPTG when the
culture reached an OD600 between 3-5, and allowed to grow for 16 hours without O2
supplementation. The cell pellet was collected by centrifugation (5000 x g, 20 min, 4oC) and
resuspended in His buffer (50 mM NaPO4, pH 8.1, 5 mM glucose, 150 mM NaCl, 0.1% Tween).
Cells were passed through a cell disruptor (Constant Cell Disruption Systems, Sanford, NC) for
lysis. After clearing the lysate by centrifugation, the supernatant was run on a 50 ml ProBind
column (Invitrogen, Eugene, OR) at a rate of 5 ml/min on a FPLC (GE Lifesciences, Piscataway,
NJ) with a step gradient of 5 to 250 mM imidazole in His buffer. Fractions were screened using
HK activity assays and Western blotting and those containing rTbHK1 were pooled and
concentrated. Further purification by ion-exchange chromatography was performed using a
HiTrap SP HP column (GE Lifesciences, Piscataway, NJ) with a gradient elution. At the end of
the purification, the protein was determined to be ~99% pure based on SDS-PAGE.
HK assays were performed as described in triplicate using a coupled reaction to measure
enzyme activity (Morris et al., 2006; Misset and Opperdoes, 1984). In short, the coupled assay
uses glucose-6-phosphate dehydrogenase (G6PD) to convert glucose-6-phosphate (G6-P)
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generated by HK to 6-phosphogluconate with coincident reduction of NADP to NADPH, which
is monitored spectrophotometrically at 340 nm. Reagent final concentrations in the 200 µl
reactions were (unless otherwise noted): 50mM triethanolamine (TEA)/ 3-(N-morpholino)
propanesulfonic acid (MOPS)/ piperazine-N,N’-bis (2-ethanesulfonic acid) (PIPES), 3.3mM
MgCl2, 20mM glucose, 5.25mM ATP, 0.75 mM NADP, and 0.1 units of G6PDH. For protection
assays, Gly3P (20 mM) was added with the other assay components. Kinetic analyses were
performed using KaleidaGraph 4.1 (Synergy Software, Reading, PA) with the Michaelis-Menten
curve fit algorithm.

Enzyme activity in parasite lysates - PF or BSF parasites were lysed as described above. Cell
equivalents (1 x 105 or 4 x 105 for PF and BSF, respectively) were mixed with all HK assay
components and the HK reaction monitored spectrophotometrically.

Tryptophan Quenching Assay of TbHK1 –Quercetin (QCN) (varying concentrations) and Gly3P
(20mM) were added individually and in combination to a solution (3 mL) of 0.1M MOPS, pH
6.5. A scanning spectrofluorometer (QM-Y, Photon Technology International, Birmingham, NJ)
was used to monitor emission from 300-550 nm after excitation of the lone Trp on TbHK1
(W177) at 280 nm (Dodson, 2010). Once background emission was acquired, ~1 ug of TbHK1
was added to the cuvette, mixed by pipetting and a second emission scan was performed. Using
Photon Technology International (PTI) software, the area under the emission curve from 370380nm was integrated. The values were converted to Trp emission lost and plotted versus
concentration of QCN using KaleidaGraph 4.1 (Synergy Software, Reading, PA) to determine
IC50 values.
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RESULTS
Starvation triggers altered abundance of some glycosome-resident proteins. PF
trypanosomes can adapt their metabolism to conditions of low glucose, presumably by upregulation of amino acid metabolism (ter Kuile, 1997; McCann et al., 2008). Because of this
dynamic metabolism, PF parasites can grow normally in the near absence of glucose. Complete
denial of nutrients by incubation in phosphate-buffered saline, however, has been shown
previously to trigger association of glycosomes with the lysosomal compartment in PF cells, a
process similar to pexophagy in yeast (Herman et al., 2008).

Figure 3.1. Incubation of PF parasites in PBS leads to altered abundance of glycosomeresident proteins.
6

7

Whole cell lysate from parasites maintained in SDM 79 (5x10 or 1x10 cells, lane 1 and 2, respectively)
6

7

or incubated in PBS for 15 min (5x10 or 1x10 cells, lane 3 and 4) were probed with antisera raised
against glycosomal residents (TbGK, TbHK, TbTIM), a glycosomal membrane protein (TbPEX11)
(Lorenz et al., 1998) and a cytosolic protein (TbENO).
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To assess the consequence of association of glycosomes with acidic compartments,
parasites were grown under standard conditions or incubated in PBS, a process known to trigger
trypanosomal autophagy (Herman et al., 2008) and cell lysates probed with antisera to
glycosomal resident proteins and cytosolic proteins. Incubation in PBS led to a modest decrease
in TbHK signal (likely a mixture of TbHK1 and TbHK2, as the antisera does not discriminate)
(Figure 3.1, lanes 3 and 4). TbGK abundance is not depleted, while TbTIM levels are markedly
reduced. The impact of incubation in PBS is not systemic, as the cytosolic-resident glycolytic
enzyme TbENO and the glycosomal membrane protein TbPEX11 are not impacted. These
findings are similar to those reported in earlier studies on autophagy (pexophagy) of glycosomes
that occurs after brief incubation of cells in PBS or during differentiation (Herman et al., 2008).
TbHK1 is pH sensitive, but Gly3P prevents inactivation. To explore the potential impact
of fusion of the glycosome with the acidic (pH 4.8) lysosome (McCann et al., 2008) on a
glycosome-resident protein in vitro, purified recombinant TbHK1 was assayed under different
pH conditions. The recombinant enzyme, normally assayed at pH 7.4, is sensitive to acidic
conditions, with ~ 50% reduction in activity at pH 7.0 and nearly complete loss of activity at pH
6.5 (Fig. 3.2A).
Glycosomes are dynamic organelles that are subject to changes in pH and enzyme and
metabolite content, depending on both the environment in which the cell resides and the life
cycle stage. For example, PF parasites grown in amino acid-based media rapidly supplemented
with glycerol quickly accumulate Gly3P from undetectable levels to ~ 15 mM within an hour
(Haanstra et al., 2008). This increase is attributed to the activity of the sole cellular glycerol
kinase (GK), a glycosome-resident protein (Haanstra et al., 2008). The dynamic nature of
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glycosome contents led us to consider the impact of Gly3P on pH-mediated inactivation of
TbHKs.

Figure 3.2. TbHK1 inhibition under acidic conditions can be prevented by inclusion of Gly3P in
the assay.
70

(A) pH profile of TbHK1 (150 ng) activity in the presence (white) or absence (black) of Gly3P. Three
different Good’s Buffers with buffering capacity in the range of pH tested were used for the assay:
MOPS, PIPES and TEA. (B) TbHK1 activity in MOPS buffer at pH 7.4 or 6.5 with or without Gly3P,
Gly2P, or glycerol (Gly) (20 mM each).

Performing TbHK1 assays under acidic conditions in the presence of Gly3P modulated
pH inactivation of the enzyme (Fig. 3.2A). At pH 6.5, more than 50% of the TbHK1 activity
observed at pH 7.4 was maintained when Gly3P was included. Notably, detectable enzyme
activity was maintained at pH 4.0 (the lowest pH tested) in the presence of Gly3P (Figure 3.3).

Figure 3.3 pH profile of rTbHK1 activity +/- Gly3P
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Hexokinase assays were conducted in reaction mixture using 50 mM TEA buffer from pH 4.0 to 8.0 with
ATP as a phosphoryl donor.

The pH of the reaction mixture remained unchanged after Gly3P addition, ruling out the
possibility of Gly3P buffering the reaction. In parallel experiments lacking Gly3P, the enzyme
was inhibited at pH 7.0 (Fig. 3.2A). Gly2P also prevented inactivation while glycerol did not
(Fig. 3.2B). Gly3P has no impact on TbHK1 oligomerization (a previously characterized
mechanism for regulation of activity (Chambers et al., 2008)) indicating that the maintenance of
enzyme activity that we observed is not related to a change in the nature of the hexamer (Fig.
3.4). While Gly3P may be serving as a molecular crowding agent that abrogates the impact of
pH or temperature, substituting glycerol or PEG did not prevent inactivation, suggesting that if
the observed results were due to crowding, it was a specific response to glycerophosphate
compounds.

Figure 3.4. Resolution of rTbHK1 oligomers at pH 7.4 with various metabolites present.
rTbHK1 was incubated for 30 minutes at pH 7.4 in the presence of glucose (Lanes 2, 9) glucose and ATP
(Lanes 3, 10), glucose, ATP and Gly3P (Lane 4), glucose and Gly3P (Lanes 5, 11), ATP and Gly3P
(Lanes 6,12) or Gly3P alone (Lane 7,13) prior to resolution on a 4% native gel (as described in Chambers
et al., 2008).
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To ensure that the protection of the recombinant enzyme was not an artifact of the
coupled enzyme assay, G6PDH was incubated at pH 6.0 with G6-P as substrate, thereby
foregoing the need for HK to produce G6-P from ATP and glucose. G6PDH activity was
unaffected by the acidic pH, readily converting G6-P to 6-phosphogluconate at the acidic pHs
tested here, in the presence or absence of ATP and glucose (Fig. 3.5). Therefore our
observations are not a result of altering the G6PDH coupled enzyme activity.

Figure 3.5. G6PDH activity at pH 7.4 and pH 6.0 with or without Gly3P.
A reaction mix of G6PDH (0.1 units/reaction), glucose-6-phosphate (20mM), and NADP (0.75mM)
buffered to pH 7.4 (left) or 6.0 (right) was supplemented with or without Gly3P (20mM) and G6PDH
activity measured spectrophotometrically at 340 nm.

Gly3P and Gly2P, but not glycerol, also maintained authentic TbHK activity from both
procyclic form and bloodstream form cell lysate at low pH (Figs. 3.6A and 3.6B). These
findings again suggest that the glycerol moiety is not merely serving as a protective agent but
rather that the phosphate is important in maintaining activity.
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ATP and ADP are inhibitory under acidic conditions. The observation that Gly3P or
Gly2P altered rTbHK1 activity led us to consider whether the change in pH was somehow
altering the interaction of the protein with other phosphoryl-bearing compounds, including the
substrate ATP. At pH 7.4, a broad range of ATP concentrations support TbHK1 activity with an
inhibitory consequence on activity only at very low (0.1 mM) and very high (15 mM)
concentrations. At pH 6.5, however, the enzyme is more sensitive to the substrate, with optimal
activity at ~1 mM (Fig. 3.7A) and inhibition at higher concentrations. The affinity for ATP does
not change dramatically at pH 6.5 (apparent Km of 0.22 ± 0.17 mM, compared to 0.28 mM at pH
7.4 (9)). The addition of Gly3P only slightly increases the apparent affinity to 0.16 ± 0.07 mM at
pH 6.5.
Supplementing the low concentration of ATP (1 mM) needed to fuel the TbHK1 reaction
at pH 6.5 with ADP inhibited the enzyme (Fig. 3.7B). ADP is a mixed inhibitor of TbHK1 (Fig.
3.7C), with an IC50 of 4.2 mM. The impact of ADP on the assay at pH 7.4 was reduced, yielding
an IC50 of ~ 10 mM. Similar experiments using AMP in lieu of ADP did not inhibit the enzyme.
Additionally, introduction of additional MgCl2 into the reaction did not reverse inhibition,
indicating that the inhibition was not a result of the nucleotide depleting Mg2+ required for
enzyme function.
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Figure 3.6. Hexokinase Activity in Cell Lysate with various glycerol moieties.
BSF lysate (4 x 105 cell equivalents (A)) or PF lysate (1 x 105 cell equivalents, (B)) were assayed for HK
activity at pH 7.4 (black) and pH 6.5 (white) with or without the addition of Gly3P, Gly2P or Gly (all at
20 mM).
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Figure 3.7. Substrate and product inhibit TbHK1 under acidic conditions.
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(A) TbHK1 (150 ng) activity was assayed under acidic conditions (pH 6.5) including ATP from 0-20 mM
in the assay. (B) TbHK1 activity assessed in the presence of 1 mM ATP (competent for activity)
supplemented with ADP (0-20 mM) at pH 6.5. (C) ADP is a mixed inhibitor of TbHK1 at pH 6.5.
Assays, performed as described in the Materials and Methods, were plotted using KaleidaGraph 4.1
(Synergy Software, Reading, PA) with the Michaelis-Menten curve fit algorithm.

Quercetin inhibition, but not binding, is relieved by Gly3P at pH 6.5. To further
characterize the interaction of Gly3P with TbHK1, we employed a fluorescent probe, quercetin
(QCN), which inhibits TbHK1 with an IC50 of 4.1 ± 0.8 µM at pH 7.4 (Dodson et al., 2010).
Additionally, QCN quenches fluorescence from the lone Trp residue (Trp177) that lies near the
enzyme hinge adjacent to the catalytic base, Asp214 (Dodson et al., 2010). At a concentration of
QCN near the IC50 (10 mM), Gly3P prevents inhibition at pH 7.4, but fails to prevent
inactivation by higher QCN concentrations (Fig. 3.8A). Notably, at pH 6.5, QCN inhibition is
abolished in the presence of Gly3P.
To explore the consequences of Gly3P on QCN binding, TbHK1 was incubated with
increasing concentrations of QCN in the presence or absence of Gly3P and the consequences on
Trp177 emission assessed. Under standard conditions (pH 7.4), QCN quenched 50% of Trp177
emission at 35 µM (Dodson et al., 2010). At pH 6.5, emission was similarly quenched by QCN,
independently of the presence of Gly3P (yielding 50% quenching at 43 and 50 µM QCN, with or
without Gly3P, respectively) (Fig. 3.8B).
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Figure 3.8. QCN inhibition is relieved in the presence of Gly3P at pH 6.5.
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(A) TbHK activity in the presence or absence of Gly3P with varying concentrations of QCN (10 or 100
µM). (Please note that at pH 6.5 in the absence of Gly3P, activity is not detected, hence the lined bar is
not visible.) (B) Trp177 emission is quenched by QCN at pH 6.5 in the absence (left) or presence (right)
of Gly3P. Increasing concentrations of QCN were incubated with rTbHK1 in a 100 mM MOPS, pH 6.5
solution. Trp177 was excited at 280 nm followed by an emission scan from 300-550nm. The percentage
of Trp emission lost upon addition of QCN was calculated from the emission peak between 370-380 nm.

DISCUSSION
T. brucei alternates between a tsetse fly vector and mammalian host, utilizing changes in
environmental nutrient availability as part of a complex pathway to regulate development. These
changes include activation of “cryptic” mitochondrion in the BSF to a metabolically active
organelle in the PF parasite. Additionally, glycosome contents are altered in a developmentally
coordinated fashion. For example, BSF parasites metabolize glucose to 3-phosphoglycerate (3PGA) within the glycosome, followed by further processing in the cytosol to ultimately yield
pyruvate. PF parasites, however, process glucose to 1,3-bisphosphoglycerate in the glycosome,
indicating that the parasite utilizes stage-specific differences in glycosomal content to regulate
metabolic pathways.
Changes in glycosome content occur through glycosomal autophagy (Herman et al.,
2008). During differentiation, glycosomes co-localize with lysosomes, which occurs particularly
quickly (and involves a high percentage of glycosomes) during the transition from short-stumpy
form parasites (the mammalian blood form pre-adapted for life in the insect) to PF parasites
(Herman et al., 2008). As an example of the impact of this process, the levels of the glycosomeresident protein aldolase are reduced (compared to levels in BSF) in short stumpy forms, and
then increased again in the PF form, only to slowly decrease thereafter. This process resembles
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pexophagy, the mechanism for peroxisome turn-over in methylotrophic yeast that occurs when
nutritional conditions change (Farre and Subramani, 2004).
Here we have found that a change in protein environment (a change in pH) impacts the
response of TbHK1 to both substrate (ATP) and product (ADP), heretofore unrecognized as
regulators of enzyme activity (Fig. 3.9). Product inhibition by ADP is not competitive with
substrate, indicating that a secondary nucleotide binding site has been exposed in response to the
acidic conditions of the assay. The change in protein structure is subtle, as the enzyme functions
at reduced ATP concentrations. Under the more acidic pH conditions, QCN quenches Trp177
fluorescence, indicating that it interacts with the protein. However, the flavonol fails to inhibit
the enzyme, suggesting that the subtle change in structure has moved the QCN binding site
sufficiently far from the active site to allow activity (Fig. 3.9).
We expect total TbHK activity to differ between BSF and PF parasites as BSF parasites
rely exclusively on glycolysis for ATP production. Reflecting metabolic differences in the life
stages, glycolytic proteins make up ~90% of the protein content in BSF glycosomes, while in PF
glycosomes, only ~40-50% of the protein content is glycolytic proteins (Michels and Opperdoes,
1991; Moyersoen et al., 2004; Michels et al., 2006 ). Nevertheless, TbHKs are important to both
life stages, as TbHK1 and TbHK2 have been shown to be essential to BSF parasites (Chambers,
2008 and Albert, 2005), while TbHK2-/- PF parasites are viable but the knockout has a
pleiotropic impact on the cells. Viable TbHK1-/- PF cells have not yet been isolated despite
repeated attempts under different growth conditions (M.T. Morris, unpublished observation),
suggesting TbHK1 is also essential to PF cells.
The importance of the interaction of Gly3P with TbHKs, and the subsequent regulation of
enzyme activity, can be inferred from parasites that lack glycosomes due to genetic manipulation
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of the PEX14 gene, which is involved in peroxisomal and glycosomal protein import. As a result
of the PEX14 deficiency, glycosome biogenesis is blocked, yielding parasites that grow normally
in the absence of glucose. However, addition of glucose to cultures of PEX14-deficient parasites
is toxic (Furuya et al., 2002). Glucose toxicity has been proposed to result from the lack of
appropriate compartmentalization of TbHKs and PFK, leading to uncontrolled consumption of
ATP (Furuya et al., 2002). Interestingly, RNAi of TbGK was found to rescue the parasites from
glucose sensitivity in the PEX14-deficient background (Haanstra et al., 2008). This observation
suggests that the absence of TbGK leads to a reduction in cellular Gly3P that therefore allows pH
inactivation of TbHK activity. Without sufficient Gly3P to maintain TbHK activity, the cell is
protected from the lethal “runaway” activity of the enzyme.

FOOTNOTES
*The authors would like to thank Dr. Jeremy Chambers for his input on the project. This work
was supported in part by the US National Institutes of Health 1R15AI075326 to JCM. A Wade
Stackhouse Fellowship in part supported HCD.

The abbreviations used are: BSF, bloodstream form; G6-P, glucose-6-phosphate; G6PDH,
glucose-6-phosphate dehydrogenase; Gly3P, glycerol-3-phosphate; GK, glycerol kinase; HK,
hexokinase; PF, procyclic form; rTbHK1, recombinant Trypanosoma brucei hexokinase 1;
TbHK, T. brucei hexokinase.
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CHAPTER 4
QUERCETIN, A FLUORESCENT BIOFLAVONOID, INHIBITS
TRYPANOSOMA BRUCEI HEXOKINASE 1
Heidi C. Dodson, Todd L. Lyda, Jeremy W. Chambers, Meredith T. Morris, Kenneth A.
Christensen, and James C. Morris
Department of Genetics and Biochemistry
Clemson University
Clemson, SC 29634

ABSTRACT
Hexokinases from the African trypanosome, Trypanosoma brucei, are attractive targets
for the development of anti-parasitic drugs, in part because the parasite utilizes glycolysis
exclusively for ATP production during the mammalian infection. Here, we have
demonstrated that the bioflavonoid quercetin (QCN), a known trypanocide, is a mixed
inhibitor of Trypanosoma brucei hexokinase 1 (TbHK1) (IC50 = 4.1 ± 0.8 µM).
Spectroscopic analysis of QCN binding to TbHK1, taking advantage of the intrinsically
fluorescent single tryptophan (Trp177) in TbHK1, revealed that QCN quenches emission
of Trp177, which is located near the hinge region of the enzyme. ATP similarly
quenched Trp177 emission, while glucose had no impact on fluorescence.
Supporting the possibility that QCN toxicity is a consequence of inhibition of the
essential hexokinase, in live parasites QCN fluorescence localizes to glycosomes, the
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subcellular home of TbHK1. Additionally, RNAi-mediated silencing of TbHK1
expression expedited QCN induced death, while over-expressing TbHK1 protected
trypanosomes from the compound. In summary, these observations support the
suggestion that QCN toxicity is in part attributable to inhibition of the essential TbHK1.
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INTRODUCTION
Trypanosoma brucei is the causative agent of human African trypanosomiasis and
nagana, a wasting disease, in livestock. The World Health Organization classifies T.
brucei as a re-emerging/uncontrollable human pathogen, partly due to a lack of a vaccine
and suitable treatments for the disease. Current therapeutics for human African
trypanosomiasis (HAT) may have serious side effects, including blindness and death
(Barrett et al., 2003).
T. brucei relies exclusively on glycolysis for ATP generation in the mammalian
bloodstream. Hexokinases (HK) catalyze the first step in glycolysis facilitating the
transfer of the γ-phosphoryl group of ATP to the C6 of glucose. The parasite expresses
two HKs, TbHK1 and TbHK2, with proteomic studies revealing that both are found in
the mammalian bloodstream (BSF) and insect (PF) forms of the parasites (Colasante, et
al., 2006). Both the proteins reside in an unusual organelle called the glycosome that
houses the majority of the enzymes that participate in glycolysis.
TbHK1 and TbHK2 are 98% identical at the amino acid level (Morris, et al.,
2006). RNA interference (RNAi) has been used to demonstrate that both enzymes are
essential to the BSF parasites, as silencing of either TbHK1 or TbHK2 results in the loss
of HK activity and cell death (Albert et al., 2005; Chambers et al., 2008). In addition to
this genetic evidence validating TbHKs as potential therapeutic targets, we have found
that chemicals that inhibit HKs from other systems also inhibit TbHKs and are toxic to
the trypanosome. For example, the anticancer drug lonidamine (LND), which functions
in part by inhibiting human HK (Floridi and Lehninger, 1983; Paggi et al., 1988), inhibits
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both recombinant TbHK1 and HKs from parasite lysate. Additionally, LND is toxic to
BSF and PF parasites (Chambers et al., 2008), likely as a result (at least in part) of
inhibition of TbHKs. Supporting this, parasites were partially protected from LNDinduced cell death by ectopic over-expression of TbHK1.
Quercetin (3,5,7,3’,4’ pentahydroxyflavone, QCN) is an abundant naturally
occurring flavanol found in plants such as apples, onions, and capers. QCN and related
flavanols are of interest as potential anti-cancer therapies, because they inhibit the growth
of several types of cancer cell lines (Molnar et al., 1981; Suolinna et al., 1975). Potential
in vivo QCN targets include a number of enzymes that are inhibited in vitro, ranging from
the Src protein kinase (pp60v-src) to HKs (Graziani, 1977; Graziani, et al., 1983).
Biophysically, QCN has several unusual fluorescence properties, including
intramolecular excited-state proton transfer and dual fluorescence behavior that have
been exploited in the use of flavanols as environmental probes (Guharay et al., 2001).
Additionally, QCN binding to bovine serum albumin has been studied using these
spectral properties (Sengupta and Sengupta, 2002).
Here, we have characterized the impact of QCN on recombinant TbHK1 and
transgenic parasites. Our work builds on the observation that QCN is toxic to
trypanosomes (Mamani-Matsuda et al., 2004), revealing that TbHK1 may be a molecular
target of the flavanoid. We have found that over-expression of TbHK1 provides
protection from QCN, while RNAi depletion of TbHKs expedites parasite death.
Additional spectroscopic investigations taking advantage of the intrinsic fluorescence of
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QCN suggest that QCN toxicity may be due in part to binding near the TbHK1 active
site, causing enzyme inactivation.

MATERIALS AND METHODS
Reagents
QCN (3,3’,4’,5,7-pentahydroxyflavone) was purchased from Spectrum Chemical
Manufacturing Corporation (Gardena, CA).

Assays of recombinant and lysate-derived TbHK
Recombinant TbHK1 was expressed and purified as described previously (Morris et al.,
2006). Parasite lysates were prepared by hypotonic lysis of 1 x 107 cells in the presence
of 1 mM PMSF, 20 µg/ml leupeptin, and 100 µg/ml TLCK. The mixture was added to
lysis buffer (for a final concentration of 0.1 M triethanolamine (TEA) pH 7.4 and 0.1%
Triton X-100) and lysates used in HK assays.
HK assays were performed in triplicate using a coupled reaction. Briefly, assays
used glucose 6-phosphate dehydrogenase (1 unit/assay, EMD Biosciences, Inc, Sand
Diego, CA) as a coupling enzyme to reduce NAD+ to NADH during the oxidation of
glucose-6-P to 6-phosphogluconic acid (Morris, et al., 2006), a reaction that can be
monitored spectrophotometrically. Final conditions were 0.1M TEA, pH 7.9 containing
1.0 mM ATP, 33 mM MgCl2, 20 mM glucose, and 0.75 mM NAD+. Assays were
performed in 96-well microtiter plate format in a GENios spectrophotometer (Tecan
Group Ltd., Switzerland).
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Tryptophan Quenching Assay of TbHK1
Glucose (20 mM), QCN (50 µM) and ATP (varying concentrations) were added
individually and in combination to a solution (3 ml) of 0.1M TEA, pH 7.4. A scanning
spectrofluorometer (QM-Y, Photon Technology International, Birmingham, NJ) was used
to monitor emission from 300-550 nm after excitation of the lone Trp on TbHK1 (W177)
at 280 nm. After acquiring background emission, TbHK1 (~1 µg) was added to the
cuvette, mixed by inversion, and an emission scan performed. Using the Photon
Technology International software, the area under the emission curves from 370-380 nm
was integrated. Values were converted into the percent of Trp emission lost and plotted
versus concentration of substrate/inhibitor using KaliedaGraph software version 4.03.
Sigmoidal curves were fit to the plots and IC50 values were determined for the
substrate/inhibitor by setting y equal to 50 and solving for x using the sigmoidal equation.

QCN Localization in T. brucei by Fluorescence Microscopy
PF parasites (29-13, a 427 strain) were grown in SDM-79 with the T7 RNA polymerase
and the tetracycline repressor constructs maintained by the addition of 15 µg/ml G418
and 50 µg/ml hygromycin to the medium. BSF parasites (cell line 90-13, a 427 strain)
were grown in HMI-9 supplemented with 10% fetal bovine serum and 10% Serum Plus
(Sigma-Aldrich, St. Louis, MO) with the T7 RNA polymerase and the tetracycline
repressor constructs maintained by the addition of of 1.5 µg/ml G418 and 5 µg/ml
hygromycin to the medium.
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For microscopic examination of QCN localization, T. brucei were grown to 1 x
107/ml (PF 29-13) or 1 x 106/ml (BSF 90-13), harvested (800 x g, 10 min), and washed
twice in modified PBS (5 mM KCl, 8 mM NaCl, 1 mM MgSO4, 20 mM Na2HPO4, 2 mM
NaH2PO4, 20 mM glucose). QCN (100 µM) was then added to cells in the modified
PBS. After incubation (15 min, at growth conditions), cells were pelleted, washed twice,
and applied to slides after the addition of VectaShield mounting medium with DAPI
(Vector Laboratories, Inc., Burlingame, CA). Images were captured by epifluorescence
microscopy (Axiovert 200M, Carl Zeiss MicroImaging, Inc., Thornwood, NY).
For glycosome labeling, the aldolase peroxisomal targeting sequence (PTS2)
(Blattner et al., 1995) was introduced into a red fluorescent protein (mCherry) modified
pXS (Marchetti et al., 2000) expression vector to yield an N-terminal fusion with the
mCherry. Briefly, FPTS2 (5’AGCTTATGAGTAAGCGTGTGGAGGTGCTTCT
TACACAGCTTG 3’) and RPTS2 (5’CTAGCAAGCTGTGTAAGAAGCACCTCCAC
ACGCTTACT CATA 3’) were annealed and the resulting product cloned into pXS. PF
parasites were then transiently transfected with 10µg of the pXSAldoPTSmCherry
construct and cultured 24 hr prior to examination. Live cells were visualized after
resuspension in mounting medium (with DAPI) diluted 1:1 in PBS.
For RNAi studies, PF parasites were transfected and stable transformants selected
as described (Wang et al., 2000). TbHK1 was targeted specifically using an RNAi
construct that targeted the unique 3’UTR of the transcript. Briefly, RNAi of TbHK1 was
achieved using pZJM harboring a 341 bp fragment previously identified as a 3'
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untranslated region sequence (Morris et al., 2002). Parasite growth was monitored on a
Becton-Dickinson FACScan flow cytometer.
For studies exploring the impact of over-expression of TbHK1 in PF cells,
parental cells (PF 29-13) were transformed with linearized pLew111(2T7)GFPb (Motyka
et al., 2006) harboring the TbHK1 gene in the multicloning site. This vector fuses the
green fluorescent protein (GFP) to the carboxyl termini of expressed proteins. After
selection for stable transformants, TbHK1 expression was induced by addition of
tetracycline (1 µg/ml) to the media.

RESULTS
Glycolysis is essential to the parasitic protozoan T. brucei, suggesting that
inhibitors of enzymes in the pathway may be suitable targets for therapeutic
development. TbHK1, which mediates the first step in this metabolic pathway, is an
enzyme that has previously demonstrated to be essential for BSF parasites (Chambers et
al. 2008a). As part of the validation of a high throughput screening campaign, we
completed a pilot screen of a library of 1280 pharmaceutically active compounds
(LOPAC, Sigma) (Sharlow et al, 2009.). This screen yielded 12 primary hits including
myricetin (IC50 of 48.9 ± 0.7 µM), a bioflavonoid that shares structural similarity with a
known anti-trypanosomal compound, QCN (Fig. 4.1A) (Mamani-Matsuda et al., 2004).
Further, the observation that QCN inhibited mammalian HKs (Graziani, 1977) suggested
that the trypanosome TbHK1 could be a target of QCN. These observations led us to
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further explore QCN as an inhibitor of TbHK1 while considering the possible connection
between TbHK1 inhibition and the reported anti-parasitic activity of QCN.

QCN inhibits TbHK1 through mixed inhibition with ATP
Incubation of recombinant TbHK1 with QCN followed by a coupled enzyme assay for
HK activity revealed that the compound inhibited the enzyme (IC50 = 4.1 ± 0.8 µM) (Fig.
4.1B). Inhibition was not as a result of dissociation of TbHK1 oligomers (a previously
characterized mechanism for regulation of activity (Chambers et al., 2008)), as QCN did
not cause dissociation of TbHK hexamers.
Many different kinases are inhibited by QCN, indicating that the molecule
interacts with a structural feature common to all of the proteins, with the ATP binding
site being a likely candidate binding site (Matter et al., 1992; Srivastava, 1985; Granot,
2002). Analysis of the nature of TbHK1 inhibition revealed that QCN was a mixed
inhibitor with respect to ATP with a Ki value of 2.9 ± 0.9 µM (Fig. 4.1C).
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Figure 4.1. QCN is a potent inhibitor of TbHK1.
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(A) Structures of myricetin and QCN. IC50s for rTbHK1 are reported below the structure.
(B) QCN inhibits rTbHK1. Increasing amounts (0-100 µM) of QCN were incubated with
rTbHK1 (160 ng/assay) for 10 min at RT and HK assays were performed as described in the
Materials and Methods. Please note that due to the complex nature of the mode of inhibition, IC50
values were estimated assuming single site binding. (C) QCN is a mixed inhibitor of TbHK1
with respect to ATP. Michaelis-Menten plots of inhibition with different QCN concentrations in
assays containing varied ATP amounts.

To determine if endogenous HK activity from parasite lysates was also sensitive
to QCN inhibition, cell lysates from BSF or PF parasites were incubated with QCN and
then assayed for HK activity. QCN inhibited both BSF and PF HK activity similarly,
with IC50s = 24 µM and 30 µM, respectively.

TbHK1 inhibition coincides with changes in Trp177 fluorescence
TbHK1 harbors a single Trp (residue 177) that is modeled to lie on the face of the
enzyme near the hinge region and catalytic base (Asp214) (Fig. 4.2A) (Morris et al.,
2006). Excitation of the single Trp177 in TbHK1 at 280 nm yielded a characteristic Trp
emission band at ~370 nm (Fig. 4.2B, inset). While QCN is intrinsically fluorescent with
a maximum emission wavelength of 550 nm when excited at 280 nm, it alone yielded
little fluorescence at 370 nm. Addition of increasing amounts of QCN to TbHK1,
however, quenched the Tryp177 emission, yielding an IC50 for quenching of ~ 35 µM
(Fig. 4.2B).
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To further resolve the impact QCN was having on Trp177 emission, substrates of
TbHK1 were included to determine their impact on fluorescence. Addition of glucose
(20 mM) alone did not alter Trp177 emission at 370 nm (not shown). However, addition
of ATP (0.05 mM) quenched the Trp177 emission ~20%, while additional ATP (to 5
mM) nearly eliminated emission (Fig. 4.2C). Addition of glucose with the ATP did not
alter quenching, yielding emission loss similar to ATP alone.
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Fig. 4.2. QCN bound to rTbHK1 alters Trp177 fluorescence.
(A) TbHK1 was modeled to the crystal structure of S. cerevisiae hexokinase PII (Kuser et al.,
2000). The active site, Asp214, and Trp177 are indicated, along with residues that are involved
in ATP binding in the C-terminal tail. For clarity, the lower lobe of the protein has been isolated
and rotated to position the C-terminal tail perpendicular to the page. (B) Trp177 emission is
inhibited by QCN. TbHK1 (1 µg) was incubated with increasing concentrations of QCN in a 100
mM TEA (pH 7.4) solution and, following excitation at 280 nm, emission monitored from 340500 nm. To assess the percentage of Trp emission lost, the region between 370-380 nm (inset)
was calculated and the % reduction in response to QCN determined. (C) ATP and QCN quench
Trp177. Spectra were acquired from samples containing different amounts of ATP as described
in 2B, and percentage of Trp emission lost calculated. Glucose (20 mM) was added as indicated.

QCN localizes in part to glycosomes in live trypanosomes
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Little is known about the mechanisms of action of QCN in the African trypanosome but
the observation that the compound inhibits the essential TbHK1 led us to consider if the
two shared subcellular localization. To explore this, live PF parasites expressing
glycosomally targeted mCherry were incubated with QCN and the fluorescence both
scored by microscopy (Fig. 4.3A). QCN accumulated in distinct foci, yielding punctate
fluorescence that co-localized with the mCherry-bearing glycosomes. Additional QCN
fluorescence was observed as a light haze throughout the cell, suggesting that localization
was not limited to glycosomes. (Please note, parasite autofluorescence was not observed
when similar exposure times were used on cells not incubated with QCN, suggesting the
diffuse signal is due to the compound.) Similarly, live BSF parasites yielded QCN
fluorescence in punctate foci, a distribution suggesting subcellular localization,
potentially glycosomal in nature (Fig4. 3A). Additional staining was observed associated
with the flagellum.
The glycosomes, a peroxisome-like organelle, compartmentalizes the majority of
the glycolytic enzymes in the trypanosome, many of which have been demonstrated
genetically to be essential, including TbHK1 (Chambers et al., 2008). The localization of
a compound that inhibits TbHK1 in vitro to the compartment that houses the essential
enzyme perhaps explains the cytotoxicity of the compound. Previous research
demonstrated that QCN is toxic to T. b. gambiense (LD50 = 10 µM) (Mamani-Matsuda et
al., 2004). To confirm that our 427 T. b. brucei lab strain was also susceptible to QCN,
parasites were incubated for 24 hr in the presence of compound and growth monitored by
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cell counting. QCN was found to be toxic to both BSF 90-13 and PF 29-13
trypanosomes (LD50 = 7.5 µM and 35 µM, respectively).

Figure 4.3. Localization and genetic manipulation studies to explore the biological
consequences of QCN on T. brucei.
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BSF and PF parasites incubated with QCN (100 µM, 15 and 10 min for PF and BSF,
respectively) were stained with DAPI and imaged. Glycosome localization in live PF cells was
visualized by mCherry emission. Fluorescence of the QCN does not bleed into the mCherry
spectra and was captured using a 488 nm filter set. Scale bar = 10 µm. (B) RNAi of TbHK1
enhances QCN toxicity, while over-expression of TbHK1 tempers it. Parental PF trypanosomes
(29-13) or parasites transformed with pLEW111(2T7):TbHK1 or pZJM:TbHK1 were induced
with tetracycline (1 µg/ml) for 24 hours to either express or silence TbHK1, QCN (50 µM,
dashed columns) added, and cell viability scored after an additional 24 hour incubation. All
assays were performed in triplicate, with cell numbers normalized to untreated controls. The pvalues for untreated and treated parental 29-13 and pZJM:TbHK1 bearing cells were statistically
significant (p < 0.05 in both cases), indicating that the differences between untreated and treated
cells were significant, while the value for pLEW111(2T7):TbHK1 harboring cells incubated with
or without QCN was not (p > 0.05)

Exploring potential in vivo targets of QCN
Unlike BSF parasites (which rely exclusively on glycolysis for ATP production), genetic
manipulation of glycolytic enzymes, including over-expression and RNAi-based
silencing, can be tolerated in PF parasites if the trypanosomes are first provided an
opportunity to down-regulate hexose metabolism (Morris et al., 2002; Morris et al.,
2006). If QCN is toxic as a result of its inhibition of glycolysis, increased cellular
TbHK1 polypeptide could temper the toxicity of the compound. To explore this, PF cells
over-expressing TbHK1 from the inducible ectopic expression vector pLew111(2T7)
were incubated with 50 µM QCN and cell growth compared to parental cell lines grown
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under similar conditions (Fig. 4.3B). After 24 hrs, cells over-expressing TbHK1
displayed cellular HK activity 2.1 greater than control cells. Additionally, these cells
were more resistant to QCN with growth reduced only 10.1 ± 0.5% while growth of
QCN-treated control parasites was repressed 55.5± 0.5%.
The incomplete penetrance of RNAi (and the slowly developing phenotypes
associated with the silencing) allows manipulation of TbHK1 abundance without
detectable cell toxicity in PF parasites (Morris et al., 2002). Therefore, we have explored
the consequence of silencing TbHK1 on QCN sensitivity, with the prediction being that
these cells may be more sensitive to the compound (that is, the remaining TbHK1 that
results from incomplete penetrance will be inhibited more readily by QCN). RNAi of
TbHK1 using pZJM (TbHK1), which targets the distinct 3’UTR of TbHK1 (Morris et al.,
2002), was induced for 24 hours before cells were passed into medium containing QCN
and cell growth compared to parental PF 29-13 parasites after an additional 24 hours.
Silencing TbHK1 led to enhanced sensitivity to QCN, with cells induced to silence
TbHK1 reduced in number to 16.4 ± 0.6% of the corresponding untreated cell lines (Fig.
4.3B).

DISCUSSION
BSF T. brucei generate ATP exclusively by glycolysis, indicating that inhibitors of
enzymes in the pathway may be therapeutic lead compounds. The trypanosome
glycolytic enzymes, TbHK1 and TbHK2, are potential drug targets. These proteins,
which are 30-33% identical to those from yeast, plants, and mammals, have a number of
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unique biochemical features (in addition to amino acid composition) that suggest that
identification of trypanosome-specific HK inhibitors may be possible. These differences
include mulitmerization of the enzyme into hexamers, localization of the protein to the
glycosome, and sensitivity of the TbHKs to fatty acids (Chambers et al., 2008; Misset
and Opperdoes, 1984; Morris et al., 2006).
Genetic studies using RNAi have shown that both TbHKs are essential to the
parasite (Albert et al., 2005; Chambers et al., 2008), and chemical inhibitors of the
enzyme have demonstrated anti-parasitic activity in vitro (Chambers et al., 2008; Sharlow
et al.; Willson et al., 2002). Here, we report that QCN, a previously recognized antitrypanosomal flavanoid (Mamani-Matsuda et al., 2004), inhibits recombinant TbHK1.
Amongst the mammalian enzymes that have been reported to be sensitive to QCN,
including a tyrosine protein kinase, a phosphorylase kinase (Srivastava, 1985), a
phosphatidyl 3-kinase (Matter et al., 1992), and a DNA topoisomerase (Boege et al.,
1996), the IC50s for QCN are similar to that of TbHK1, ranging from 3-300 µM. This
suggests that there may be limited increase in therapeutic range for the compound.
However, the observation that QCN is not toxic to mammals at trypanocidal
concentrations (Hu et al., 2001) supports the possibility that the partial localization of
QCN to glycosomes (and the potential for concentration of the compound therein) may
increase the therapeutic ratio favorably.
Many of the other enzymes that have been reported to be sensitive to QCN share
the feature of binding nucleotides or nucleotide triphosphates. It has been suggested that
QCN inhibits Tyr kinases (like pp60v-src) by forming a hydrogen-bonded complex with
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ATP, which would mimic the transition state of ATP and the tyrosyl residue of the
enzyme (Granot, 2002). A similar mechanism is unlikely in TbHK1, as QCN alone can
quench Trp177 fluorescence.
QCN has proven to be a potent anti-kinetoplastid agent, with toxicity toward
Leishmania donavani (Mittra et al., 2000) and T. brucei gambiense (Mamani-Matsuda et
al., 2004). In the former case, QCN inhibits DNA synthesis, leading to cell cycle arrest
that triggers apoptosis. Similarly, QCN causes T. brucei death through apoptosis
(Mamani-Matsuda et al., 2004), though we propose the mechanism may be distinct. In
mammalian cells, mitochondrial associated HK activity is required to prevent apoptosis
(Gottlob et al., 2001) and increased HK activity prevents oxidant-induced apoptosis
(Bryson et al., 2002). Our observation that QCN inhibits TbHK1 suggests that the
apoptosis may be the result of a mechanism that measures HK activity, similar to that
found in mammalian cells. The TbHKs are unusual in a number of ways, including the
finding that they oligomerize into hexamers (Chambers et al., 2008) and localize to the
peroxisome-like glycosome (Misset and Opperdoes, 1984). These characters suggest
novel mechanisms connecting TbHK to cell signaling, which remain to be resolved.
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CHAPTER 5
EXPRESSION OF TRYPANOSOMA BRUCEI HEXOKINASE 1 IS REGULATED BY
A METAZOAN-LIKE MICRORNA-BINDING ELEMENT

Heidi C. Dodson, Andrew C. Sayce, Meredith T. Morris, and James C. Morris*
Department of Genetics and Biochemistry
Clemson University
Clemson, SC 29634

ABSTRACT:
Hexokinase activity is essential in Trypanosoma brucei and tightly regulated as small
changes in expression level have dramatic consequences to cells. T. brucei expresses two
nearly identical hexokinases (TbHK1 and TbHK2) in both procyclic (PF) and
bloodstream (BSF) form parasites. While the TbHKs share 98.5% identity at the
nucleotide level from the 5’UTR through the ORF, the 3’UTRs are distinct, suggesting
regulation of expression may be controlled by 3’UTR elements. Using a deletion strategy
to remove portions of the TbHK1 and TbHK2 3’UTRs, we have identified regions in the
3’UTRs that are responsible for conferring regulation of expression. Of note, the 3’UTRs
of both genes contain putative K-box and CAAC elements. In Drosophila, these
elements bind microRNAs and function as negative expression regulators. To determine
if the putative K-box/CAAC elements are involved in differential regulation of
expression of TbHKs, we assessed the impact of point mutations in the K-box of both the
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TbHK1 and TbHK2 3’UTRs on reporter expression. While a T to G point mutation in
the TbHK1 K-box led to a 6-fold increase in expression, a similar change in the TbHK2
3’UTR K-box had no effect. Additionally, co-transfection of a synthetic anti-sense RNA,
asRNA, (to mimic the possible K-box binding partner) restored TbHK1 expression levels
suggesting that the K-box/CAAC motif may be an important element in regulating
expression of TbHK1.
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INTRODUCTION
T. brucei, the causative agent of African sleeping sickness, does not execute conventional
eukaryotic mechanisms of transcription. The protein coding regions of trypanosomatid
genomes are organized into polycistrons containing up to several hundred unrelated
genes (Haile and Papadopoulou, 2007). Transcription is accomplished in a polycistronic
fashion with every gene located on the polycistron being transcribed at the same time.
The long precursor RNAs are then processed into mature mRNAs by a coupled transsplicing and polyadenylation reaction (Sutton and Boothroyd, 1986; LeBowitz et al.,
1993). The paucity of transcription factors and RNA polymerase II promoters in the
genome and small percentage of differentially regulated genes noted in global gene
expression profiling during development suggest that gene regulation is accomplished
primarily post-transcriptionally (Clayton, 2002).
Post-transcriptional mechanisms of gene expression regulation in T. brucei
include a number of cis-acting elements found in the 3’UTRs of the regulable mRNA
(Clayton, 2002; Haile and Papadopoulou, 2007). These elements generally influence the
mRNA stability or translational efficiency of the transcript (Ouellette and Papadopoulou,
2009). Two of the most well characterized regulatory elements are found in the 3’UTR
of procyclins, a U-rich 26-mer that confers mRNA stability and a16-mer that enhances
translation in procyclic form parasites (Hehl et al., 1994).
Regulation via 3’UTR elements likely requires interaction with trans regulatory
molecules that influence the stability or translation of the transcript. For example, the
Trypanosoma cruzi U-rich binding proteins bind to mucin mRNAs and regulate their
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stage specific expression (D’Orso and Frasch, 2002). In most other eukaryotes, small
RNAs also serve as trans-regulators of gene expression. These small RNAs include
microRNAs (miRNA) and antisense RNAs (asRNA). While computational efforts
suggest that T. brucei may harbor a number of miRNAs, these have yet to be isolated
(Mallick et al., 2008). Similarly, asRNA has not been identified in T. brucei, though
Leishmania expresses sense and anti-sense forms of non-coding RNAs (Dumas et al.,
2006). The parasite does harbor the machinery to produce small RNAs, as demonstrated
by a robust RNA interference response. The role of this system, however, may be limited
to one of genome protection from retrotransposable elements (Ullu et al., 2004).
T. brucei express two hexokinases, TbHK1 and TbHK2, in both the insect form
and bloodstream form of the parasite (Colasante et al., 2006). TbHK1 and TbHK2 are
located in tandem on chromosome 10 and encode proteins that are essential to the
parasite (Morris et al., 2002; Morris et al., 2006; Berriman et al., 2005). Little is known
about the regulation of expression of these genes. While the putative 5’UTRs and ORFs
are 98.5% identical at the nucleotide level, the 3’UTRs are distinct, suggesting that
regulatory information could be housed in the 3’UTRs. Here we demonstrate the role of
a metazoan-like microRNA-binding element in the regulation of TbHK1 expression, and
present evidence that a novel asRNA is involved in the process.
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MATERIALS AND METHODS
Cell Culture and Transfections - PF parasites were grown in SDM-79 (Brun et al., 1979)
and quantified prior to transfection. A total of ~ 1.0 x 108 cells were transfected via
electroporation (ECM 830 Electroporator, BTX, San Diego, CA) with 10 µg of plasmid
DNA. After electroporation, cells were cultured in SDM-79 (28°C, 5% CO2) and CAT
assays were conducted after a 24 hour recovery period. Bloodstream form (BSF)
parasites were grown in HMI-9 media (37°C with 5% CO2) and transfected. After
electroporation, BSF parasites were allowed to recover for 24 hours (37°C, 5% CO2)
prior to lysing for assessment of CAT activity.

Cloning of constructs for CAT Assays – Presumptive 3’UTRs were amplified by PCR
from T. b. brucei genomic DNA and products cloned into pGEM (Promega, Madison,
WI) and sequenced. The TbHK1 3’UTR was amplified using F.TbHK1 3’UTR.BamHI
(5’ GATCGGATCCGTGAGAAAACCATGCTTTTC 3’) and reverse primer R.TbHK1
3’UTR.XbaI (5’ GATCTCTAGATATATATACCCTTTATTTGC 3’). TbHK2 3’UTR
was amplified with F.TbHK2 3’UTR.BamHI (5’ GATCGGATCCAGGTGA
GTGTCCGCGAACG 3’) and R.TbHK2 3’UTR.XbaI (5’ GATCTCTAGATAACCG
CTTGGATTCCTATTTTTC 3’). The pGEM inserts were subsequently used to replace
the EP1 procyclin 3’UTR in pGAPRONE (Furger et al., 1997). This construct drives
expression of the chloramphenicol acetyl transferase (CAT) gene from a procyclin
promoter and was the generous gift of Drs. Erik Vassella and Isabel Roditi (University of
Bern). Deletion constructs were generated using a Phusion Site-Directed Mutagenesis
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Kit (Finnzymes, Woburn, MA). The K-box point mutants were created by site directed
mutagenesis (QuikChange II Site Directed Mutagenesis kit, Stratagene, La Jolla, CA).

CAT Assays - CAT activity was determined using a colorimetric assay with 5’-dithiobis(2 nitrobenzoic acid) (DTNB) as indicator. In short, 24 hr after transient transfection, cell
amounts were quantified, collected by centrifugation (3,000 rpm, 10’, RT) and lysed with
water. Acetyl-CoA (100µM final concentration/reaction) was added to an optically clear
96 well plate with cell lysate followed by sequential addition of chloramphenicol (100µM
final concentration) and DTNB (0.5 µM final). In brief, CAT activity is assessed using a
colorimetric assay. The assay measures CAT activity via the transfer of the acetyl group
from acetyl-CoA to chloramphenicol. This causes the which release of a thiol group t
that then reacts with DTNB to release 2-nitro-5-mercaptobenzoic acid (TNB), which can
be monitored spectrophotometrically at 405nm.

mfold – mfold analyses were conducted using the mfold web server (version 3.2) in batch
preparation (Matthews et al., 1999). Conditions were set to default (linear RNA, 37°C,
1M NaCl, no divalent ions, 5% suboptimality, maximum interior bulge/loop size and
asymmetry 30 nt, no limit on maximum distance between paired bases). The structure
presenting the lowest initial dG was used for all subsequent analysis.

RNA cloning and in vitro transcription - A synthetic anti-sense RNA (asRNA) was
generated using primers F.TbHK1 3’UTR 1077.920RC.XhoI (5’ CACCTCGAGT
CATTCATCTCCATTC 3’) and R.TbHK1 3’UTR 1077.920RC.HindIII (5’ GTGAAGC
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TTGAGGAGAGGAATCATA 3’)to amplify the reverse strand of the TbHK1 3’UTR
from previously synthesized cDNA. This product was subcloned into the pZJMα vector
containing dual T7 promoters (Wang et al., 2000). Following HindIII linearization of the
vector, asRNA in vitro production was driven from the T7 promoters using an
AmpliScribe T7 High Yield Transcription Kit (Epicentre Biotechnologies, Madison, WI).

RESULTS
Assessment of Basal Levels of Expression of TbHK1/2
To assess differential expression of TbHK1 and TbHK2 in BSF and PF parasites,
a reporter gene system was employed to evaluate ratios of basal expression levels of these
two almost identical proteins. Putative sequences for both the TbHK1 3’UTR and
TbHK2 3’UTR, 1297nt and 500nt, respectively, were cloned downstream of a CAT
reporter gene. Expression levels were quantified relative to TbHK1 3’UTR.
Previously, analysis of steady-state mRNA levels suggested that TbHK1
transcript was ~2-fold higher than TbHK2 (Morris et al., 2006). In good agreement with
this observation, the expression from the CAT/TbHK1 3’UTR construct was about twice
that from the CAT/TbHK2 3’UTR construct in procyclic form parasites (Fig. 5.1). It
should be noted, however, that expression levels do not necessarily directly corelate with
transcript levels, especially in an organism that regulates all gene expression post
transcriptionally. Differential expression was less robust in BSF parasites, with TbHK1
expressed ~20% higher than TbHK2 (Fig. 5.1).
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Figure 5.1. Differential expression of TbHK1 and TbHK2 in PF and BSF.
CAT activity was assessed using putative full length CAT reporter constructs-TbHK1
3’UTR (1077 nt) and TbHK2 3’UTR (500 nt) in PF (top) and BSF (bottom) parasites.

Deletion Mapping of 3’UTR Regulatory Elements
Further, to identify putative regulatory elements involved in the expression of
TbHK1 and TbHK2, deletion constructs were generated by removing portions from the
proximal end or internal portion of each 3’UTR (Fig. 5.2). Deletion of the proximal 300
nt of the TbHK1 3’UTR ablated expression, suggesting that this region of the transcript
harbors a positive regulatory region (Fig. 5.2A). Additionally, removal of the proximal
400 nt yielded expression levels less than full length, exposing a positive regulatory
element located between 300-400 nt. Removal of 600 nt from the UTR yielded ~1.5-fold
higher expression. These data together suggest a negative regulatory element located
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between 300-600 nt of the UTR. Overall, the deletions revealed that the TbHK1 3’UTR
harbors several regulatory sequences to adequately regulate expression (Fig. 5.2A).
Deletion analysis of the TbHK2 3’UTR suggested the presence of a negative
regulatory element, though the mechanism is probably distinct from that of TbHK1 (Fig.
5.2B). Deletion of the first 200, 300, or 400 nt only led to modestly increased expression.
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Figure 5.2. Mapping regulatory elements using truncation of the TbHK 3’UTRs fused to a CAT reporter.
CAT reporter gene activity was assessed in constructs bearing deletions of either the TbHK1 3’UTR (A) or TbHK2 3’UTR (B-see next
page). A schematic representing regulatory elements identified from these studies is represented below each activity graph.
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Figure 5.2. (cont.) Mapping regulatory elements using truncation of the TbHK 3’UTRs fused to a CAT reporter.

121

The 3’UTRs of TbHK1 and 2 harbor potential regulatory elements
Deep sequencing of PF trypanosomes has revealed that the 3’UTR of TbHK1
contains seven polyadenylation sites following the stop codon, while the 3’UTR of
TbHK2 contains only one (Siegel et al., 2009). The seven lengths of the TbHK1 UTRs
range from 1026 nt to 1352 nt.

The core region of the UTR (the first 1026 nts) harbor

proximal (nt 430-444) and distal (nt 992-1005) K-box (cTGTGATa) and CAAC motifs
(Fig. 5.3A) (Lai et al., 1998). These elements mediate negative post-transcriptional
regulation in Drosophila (and likely other metazoa) (Lai et al., 1998), and serve as a
likely mircoRNA binding site (Lai, 2002). In the TbHK1 3’UTR proximal K-box/CAAC
motifs, the sequence and spacing between the K-box and CAAC elements is similar to
that found in K-box/CAAC motifs from metazoans (Lai et al., 1998). The distal set of
motifs, however, lacks conservation of the sequence and spacing, with the CAAC motif
5’ to the K-box. RNA m-fold analysis (Matthews et al., 1999) of the TbHK1 3’UTR
suggests that the K-box motifs are located on the same loop as their respective CAAC
element (Fig. 5.3B).
The 353 nt of the TbHK2 3’UTR contains a core K-box element (TGTGAT) at nts
150-155 with a potential CAAC motif located 40 nts downstream (nt 196-199) (Fig.
5.3B). The TbHK2 3’UTR lacks the distal K-box/CAAC motifs. RNA mfold analysis
suggests that unlike the proximal K-box/CAAC motif in TbHK1, these sequences in the
TbHK2 3’UTR reside on spatial separate loops of the mRNA (Fig.5.3B)
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A.

Figure 5.3. Tandem arrangement of TbHK genes along chromosome 10 highlighting UTR features.
(A) The 5’UTRs (black) are defined by a region of high (>98%) conservation preceding the open-reading frames. Hashed regions
indicate ORFs with the highly variable 3’UTRs in white. Putative K-box motifs are shaded in dark gray with nearby CAAC motifs in
light gray. Sequence data is given below each motif with conserved sequences underlined. (B) M-Fold analysis of the predicted structures
of the 3’UTRs for TbHK1 (Left) and 2 (Right).

123

Figure 5.3B
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Mutating the TbHK1 K-box alters expression
Deletion analysis suggested that the region of the TbHK1 3’UTR that harbors the
K-box and CAAC motifs may play an important role in regulation of TbHK1 expression.
To further assess this, a single nt change (T 431 to G) was made in the proximal K-box of
the TbHK1 3’UTR. This change led to a ~6-fold increase in CAT expression (Fig. 5.4A).
A similar change in the TbHK2 3’UTR K-box (T 150 to G) had no impact on TbHK2
expression (Fig. 5.4A).
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Figure 5.4. CAT enzyme reporter assays indicate that the proximal TbHK1 K-box
is a negative post-transcriptional regulator.
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(A)	
  Mutating	
  the	
  proximal	
  TbHK1	
  K-‐box	
  (top)	
  results	
  in	
  ~six	
  fold	
  increase	
  in	
  CAT	
  reporter	
  
enzyme	
  activity.	
  	
  Mutating	
  the	
  K-‐box	
  of	
  TbHK2	
  does	
  not	
  result	
  in	
  a	
  change	
  in	
  CAT	
  reporter	
  
activity	
  (compared	
  to	
  native	
  TbHK2	
  3’	
  UTR	
  sequence). (B) Co-transfection of TbHK1 3’ UTR
asRNA 920.1077 with CAT reporter constructs. TbHK1 3’ UTR native and mutant K-box CAT
reporter constructs were transfected or co-transfected with asRNA into PF parasites. Activity
assays demonstrate minimal change for native TbHK1 3’ UTR co-transfected with asRNA;
however, the large increase in expression observed for mutant proximal K-box TbHK1 3’ UTR
CAT constructs is restored to approximately basal expression levels when asRNA is introduced.

In an effort to further understand the mechanisms involved in the K-Box motifbased regulation, we introduced the CAT/TbHK1 3’UTR constructs into an RNAideficient background using a TbAgo-deficient cell line (the kind gift of Dr. E. Ullu, Yale
University). These results from these experiments were difficult to interpret, as
regulation of all of the reporter constructs, including the EP13’UTR control construct,
was unlike the parental control line PF29-13 (Fig. 5.5).
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Figure 5.5 CAT Expression Gene Assays in TbAgo-deficient cell line.
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TbHK1 3’UTR (1297 nt) and TbHK2 (500 nt) and TbHK1 3’UTR K-box Mutant constructs were
transiently transfected into Ago-/- cells. CAT protein expression is reported relative to the
TbHK1 3’UTR construct.

Co-transfection of a synthetic asRNA rescues TbHK1 expression
In Drosophila, dme-mir2 and dme-mir11 family miRNAs have been identified that bind
to K-box/CAAC motifs (Lai et al., 2004; Lai et al., 2005). The curious presence of the
distal CAAC/K-box, with the elements in a reversed orientation when compared to layout
of the proximal elements, suggested that transcription of the distal element could yield
RNA with partial complementary to the proximal K-box/CAAC motifs. To explore this,
we first generated in vitro a 157 nt RNA (nt 920-1077, asRNA) using sequence flanking
the distal CAAC/K-box as template. The asRNA was then co-transfected with CAT
reporter constructs and the impact on expression assessed.
Co-transfection of the asRNA with the full length CAT/TbHK1 3’UTR had
minimal impact on expression, indicating that the asRNA was not triggering an RNA
interference based repression of expression (Fig.5.4B). However, co-transfection with
the reporter construct harboring the single nt change in the K-box (which led to a 3-fold
increase in expression level) yielded a return to full length expression level. The cotransfection of the asRNA did not trigger changes in expression of unrelated genes, as
CAT expression from a construct harboring the EP1 3’UTR was not altered by the
presence of the asRNA. Additionally, the asRNA had no impact on expression of the
CAT/TbHK2 3’UTR construct.
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A native anti-sense RNA (aRNA) corresponds to the distal K box of TbHK1
While investigating the possibility that the K boxes of T. brucei are regulated by the same
mechanism as the K boxes of other species (namely a non-coding RNA such as a
miRNA), we probed for small RNAs which could contain a seed sequence
complimentary to the K box. In doing so, we produced cDNA for a 157 nt transcript
corresponding to the anti-sense strand of the TbHK1 3’ UTR at the 920th nt of the 3’ UTR
and extending to nt 1077 (Fig. 5.6). Interestingly, the distal TbHK1 K box and CAAC
motif are contained within this region on the sense strand, thus when a portion of this
strand is transcribed, a perfect reverse complement seed sequence for a K box target is
produced.

Figure 5.6. An anti-sense RNA (aRNA) is produced in vivo from the non-coding
strand of the TbHK1 3’ UTR.
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The transcript detected by cDNA production includes at least the region from nt 920 to 1077
which harbors the distal K box and CAAC motifs. This transcript is produced from a DNA strand
from which canonical polycistronic transcription in this 5’ to 3’ direction has not been identified
in this region.

DISCUSSION
Transcription in T. brucei is accomplished in a polycistronic fashion with many
unrelated genes being transcribed from the same polycistron (Haile and Papadopoulou,
2007). Therefore, most all gene regulation occurs post-transcriptionally in the parasite
with regulatory sequences controlling mRNA stability and translation often located in
3’UTRs of genes. The parasite must be able to confer regulation in a rapid manner due to
the extremely different environments encountered during its life cycle. One of the most
striking differences observed when comparing life cycle stages of T. brucei are the
metabolic pathways utilized for ATP production. This developmental difference involves
the utilization of multiple metabolic pathways in procyclic form parasites to a sole
dependence on glycolysis in bloodstream form parasites. Genes involved in these
metabolic pathways, then, must be tightly regulated according to environment and
subsequent nutrient availability. Here, we study mechanisms involved in regulating
expression of the first enzyme in glycolysis, hexokinase.
T. brucei expresses two hexokinases in both PF and BSF, TbHK1 and TbHK2,
that are 98.5 % identical at the nucleotide level. While the hexokinases exert little to no
control over glycolytic flux (Albert et al., 2006), RNAi has demonstrated that both
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TbHKs are essential (Morris et al., 2002; Albert et al., 2006) and transcript abundance of
TbHK2 demonstrates a marked increase in BSF parasites over PF parasites (Siegel et al.,
2010) suggesting that life-cycle stage dependent expression of the hexokinases is
regulated by the parasites. Further, our results indicate that study of TbHK posttranscriptional regulation may yield fundamental insights into trypanosomatid biology.
The different roles of the TbHKs in vitro (Chambers, Kearns et al., 2008; Chambers,
Fowler et al., 2008; Chambers, Morris et al., 2008; Albert et al., 2006) are appreciated,
however, the control of expression and functional significance of these differing roles has
remained largely unknown. Herein, we have demonstrated that the TbHK 3’ UTRs can
modulate differential expression of the two proteins in a stage dependent manner.
We have identified approximate regions in both TbHK1 and TbHK2 that contain
positive and negative regulatory elements controlling expression. The identification of
more than one regulatory element in the TbHK1 3’UTR suggests that regulation of this
gene is complex and influenced by many different environmental triggers.
The observation that the 3’ UTRs of both TbHKs harbor at least one copy of a K
box and associated CAAC motif identified in other species (Lai et al., 1998; Lai, 2002;
Muttray et al., 2005) is of particular interest. In these species, families of
developmentally regulated genes are often coordinately controlled by these posttranscriptional regulatory elements (Fang and Qiu, 2009; Lai et al., 2005; Li et al., 2009).
While we have not identified other members of a K-box regulated family in T. brucei, the
stage dependent switch in metabolism and associated changes in protein expression
profiles (especially of glycolytic enzymes) indicates a distinct possibility for such a
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mechanism in the parasite. In addition, variability of K-box target sequence frequency as
observed for the TbHKs occurs among other developmentally associated genes (Lai et al.,
1998) and could confer variable sensitivity or expression patterns.
In our subsequent analysis of the functional capacity of these K-box elements, the
proximal K-box of TbHK1 was revealed to confer a strong negative post-transcriptional
regulatory function. The sensitivity of this element to a single nucleotide substitution
suggests a stringent sequence requirement in agreement with the high conservation
observed in other species (Lai et al., 1998; Muttray et al., 2005; Wu et al., 2008). mfold
analysis of our mutant K-box reveals no structural changes further implying a transregulatory function. In contrast, the K-box of TbHK2 demonstrates little alteration of
expression when similarly mutated. Under standard procyclic growth conditions, it
appears as though the K-box of TbHK2 is either: 1) not a regulatory element, 2) not
stringently adherent to sequence constraints, or 3) not actively involved in regulation.
In probing for elements which contain the seed sequence complimentary to the Kbox target as would be expected of a trans- regulatory ncRNA, we have identified the
first instance of an RNA transcribed from the anti-sense strand of the 3’ UTR of a
transcript for which it is capable of altering expression in trypanosomes. This is
interesting as the transcript is produced from a DNA strand from which transcription was
previously considered unlikely as such a mechanism would not conform to canonical,
polycistronic transcription of the trypanosome genome. Whether this transcript represents
a mature ncRNA or a precursor to some smaller RNA species (such as a miRNA)
remains to be determined; however, the capacity to restore basal expression level when
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co-ordinately introduced in super-cellular concentration with a mutant proximal TbHK1
K-box reporter is suggestive of a miRNA mechanism.
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CONCLUSION
Trypanosoma brucei, the causative agent of African sleeping sickness, expresses two
hexokinases, TbHK1 and TbHK2, in both BSF and PF parasites (Colasante et al., 2006). The
current treatments available for sleeping sickness are toxic and difficult to administer in
underdeveloped countries (Brun et al., 2010). Hexokinase is considered a plausible drug target
as glycolysis is the sole method used for ATP production in bloodstream form parasites. Deeper
understandings of the regulation of gene expression and regulation of enzyme activity for this
essential protein could therefore have a great impact on development of an effective therapeutic.

Regulation of Gene Expression
The study of gene expression regulation and how it occurs in T. brucei has long been a
topic of interest due to the polycistronic organization of the genome, which results in a lack of
transcriptional regulation (Haile and Papadopoulou, 2007). It is important for TbHK1 to be
regulated properly, as previous studies reveal that misregulation of the enzyme are harmful to the
cell (Albert et al., 2005; Chambers et al., 2008).
Through studying both the TbHK1 and TbHK2 3’UTRs and searching for elements
involved in the regulation of gene expression, I have made several observations. First, regulation
of gene expression is complex and likely involves a myriad of both –cis and –trans regulatory
elements in order for gene expression to be executed properly. Initial studies to identify
elements located in the hexokinase 3’UTRs involved in regulation revealed that there was no
single element responsible for regulation, but instead this process involves several positive and
negative elements that likely act in concert to regulate expression tightly. The notable length of
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the TbHK1 3’UTR (1352 nt compared to the average of 604 nt) also supports this possibility
(Siegel et al., 2010).
Second, the complexity of the regulation is likely closely linked to the unstable
environmental conditions of the parasite. The complexity may allow the trypanosome to quickly
and efficiently adapt its gene expression to subtle (in the microenvironment) and gross
environmental changes (for example, the switch from mammalian host to insect vector). In order
for the parasite occupy diverse niches, they must first be able to sense environmental changes
effectively, and then be able to respond rapidly in order to survive. Previous studies to identify
regulatory elements in the 3’UTRs of PF surface proteins reveal that nutrients play a role in
regulating gene expression (Hehl et al., 1994). Similarly, I have shown that the hexokinases also
harbor elements in their 3’UTRs that respond to carbon source availability. I have not yet
identified the mechanism of this regulation and it likely entails regulation of both steady state
transcript and protein translation levels. However, it is clear that the parasite does change gene
expression in response to carbon source availability.
Lastly, my studies on differential polyadenylation reveal that some 3’UTR lengths are
stabilized under certain environmental conditions; however, protein is not translated under those
same environmental conditions. Though logically it seems transcribing mRNAs that are not
needed right away may not be the most efficient use of the cell resources, further thought reveals
that it may be a mechanism that the parasite employs in preparation for rapid changes. A recent
review in Science by Keith Matthews states “For such a rapid-response capability (switch from
host to vector), a common strategy is to hold pre-made mRNAs ready for translation, rather than
relying on new gene transcription and then protein synthesis (Matthews, 2011).”

139	
  

Future efforts from this work include the identification of the elements that bind the
3’UTRs, which may consist of nucleic acids and/or proteins. Further work will also involve
exploring the genome for other similarly regulated genes. A high throughput analysis of whole
genome expression of cells grown under different conditions could be utilized to identify such
genes.

Regulation of Hexokinase Activity
Mechanisms of hexokinase activity are unique in T. brucei. Unlike hexokinases in other
organisms TbHKs are not inhibited by their products (Nwagwa, 1982; Cronin, 1985). As
aforementioned, the parasite must tightly regulate hexokinase gene expression subsequently, it
must also regulate and maintain hexokinase activity under certain conditions. Here I report that
Gly3P is capable to regulate TbHK activity in an acidic environment. The discovery of this
means of regulation implies that the parasite utilizes small molecules that are readily available in
the cell to maintain the catalytic activity of this important metabolic enzyme. This regulatory
mechanism may play an important role in the maintenance of stable metabolism as the parasite
traverses through its life cycle. Similar to rapid responses in gene regulation, enzyme activity
must also remain tightly regulated to allow the parasite to effectively generate ATP as carbon
source availability and cellular conditions change.

Hexokinase as a Drug Target
Lastly, I have been involved on studies further confirming hexokinase as a viable drug
target for the T. brucei. As previously mentioned, current treatments available for
trypanosomiasis are somewhat toxic and hard to administer. Hexokinase is considered a
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plausible drug target because it is essential to BSF parasites and also due to its low similarity to
human glucokinase. I have been involved in characterization of quercetin, a previously
recognized trypanocide, as a mixed inhibitor of TbHK1. Through the study of quercetin a more
clear understanding of hexokinase binding and enzyme conformation has been revelated.
Currently, studies are underway in our lab and in collaboration with other labs to identify potent
and effective inhibitors of hexokinase that could potentially be optimized and developed into a
therapeutic. Overall, the far reaching consequences and detriment of African sleeping sickness
reveals the continued importance of studying the basic biology of the parasite to in turn be able
to develop an effective treatment for the disease.
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ABSTRACT
The parasitic protozoan Trypanosoma brucei utilizes glycolysis exclusively for ATP production
during infection of the mammalian host. The first step in this metabolic pathway is mediated by
hexokinase (TbHK), an enzyme essential to the parasite that transfers the γ-phospho of ATP to a
hexose. Here we describe the identification and confirmation of novel small molecule inhibitors
of bacterially expressed TbHK1, one of two TbHKs expressed by T. brucei, using a high
throughput screening assay.
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Methodology/Principal Findings: Exploiting optimized high throughput screening assay
procedures, we interrogated 220,233 unique compounds and identified 239 active compounds
from which ten small molecules were further characterized. Computation chemical cluster
analyses indicated that six compounds were structurally related while the remaining four
compounds were classified as unrelated or singletons. All ten compounds were ~20-17,000-fold
more potent than lonidamine, a previously identified TbHK1 inhibitor. Seven compounds
inhibited T. brucei blood stage form parasite growth (0.03 ≤ EC50 < 3 µM) with parasite
specificity of the compounds being demonstrated using insect stage T. brucei parasites,
Leishmania promastigotes, and mammalian cell lines. Analysis of two structurally related
compounds, ebselen and SID 17387000, revealed that both were mixed inhibitors of TbHK1
with respect to ATP. Additionally, both compounds inhibited parasite lysate-derived HK
activity. None of the compounds displayed structural similarity to known hexokinase inhibitors
or human African trypanosomiasis therapeutics.

Conclusions/Significance: The novel chemotypes identified here could represent leads for future
therapeutic development against the African trypanosome.
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Author Summary
African sleeping sickness is a disease found in sub-Saharan African that is caused by the singlecelled parasite Trypanosoma brucei. The drugs used widely now to treat infections are 50 years
old and notable for their toxicity, emphasizing the need for development of new therapeutics. In
the search for potential drug targets, researchers typically focus on enzymes or proteins that are
essential to the survival of the infectious agent while being distinct enough from the host to avoid
accidental targeting of the host enzyme. This work describes our research on one such
trypanosome enzyme, hexokinase, which is a protein that the parasite requires to make energy.
Here we describe the results of our search for inhibitors of the parasite enzyme. By screening
220,223 compounds for anti-hexokinase activity, we have identified new inhibitors of the
parasite enzyme. Some of these are toxic to trypanosomes while having no effect on mammalian
cells, suggesting that they may hold promise for the development of new anti-parasitic
compounds.

INTRODUCTION
African sleeping sickness conjures historical images of disease-induced fatal slumbering striking
down men, women, and children, consequently decimating villages of colonial Africa.
Unfortunately, people living in many countries of sub-Saharan Africa today know that African
sleeping sickness is not a disease of history but rather is a much-neglected disease of the present,
particularly in areas that suffer the additional burdens of war, famine, global and local climate
changes, and other infectious agents. The causative agents of sleeping sickness (or human
African trypanosomiasis, HAT) are subspecies of the African trypanosome Trypanosoma brucei.

146	
  

Approximately 500,000 people in sub-Saharan Africa are infected annually with the parasite
leading to 50,000-70,000 deaths per year [1]. Similar to other neglected tropical diseases,
limited therapeutics for HAT are available and of the drugs currently used, most have serious
adverse side effects, including encephalopathy, toxicity, and death [2]. Thus, there is a desperate
need for new HAT therapeutics with the preference shifting from general cytotoxic agents
towards molecular target-based therapeutics that should display fewer toxic effects.
Bloodstream form (BSF) T. brucei parasites generate ATP exclusively through glycolysis
and T. brucei hexokinase TbHK, the first enzyme in glycolysis, has previously been validated as
a target for therapeutic development. In these experiments, BSF parasites were shown to be
sensitive to RNA interference (RNAi)-based silencing of TbHKs [3,4], with cell toxicity
observed after 3-5 days of RNAi exposure. Additonally, known inhibitors of HKs have been
demonstrated to inhibit T. brucei hexokinase 1 (TbHK1), one of two nearly identical TbHKs that
the parasite expresses. These compounds are furthermore toxic to the parasite [4]. While some
mammalian HK inhibitors can inhibit TbHK1, TbHK1 is distinct enough from mammalian HKs
to suggest that it can be specifically targeted. Supporting this notion, TbHK1 shares only 3033% sequence identity with the mammalian HKs and differs further by unusual oligomerization
into hexamers [5]. Moreover, the unusual spectrum of known inhibitors of the trypanosome
enzymes, including fatty acids and other small molecules (like pyrophosphate, [5]), support the
idea that this essential parasite protein is sufficiently distinct from any mammalian counterpart to
make an ideal target for therapeutic development. Indeed, targeting TbHK using structurally
based inhibitors has yielded trypanocidal compounds, albeit at high concentrations [6,7].
Here we describe our high throughput target-based approach to identify specific
inhibitors of the essential parasite enzyme, TbHK1. Overall, ten compounds were confirmed as
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novel TbHK1 small molecule inhibitors exhibiting little or no similarity to known HK inhibitors
(or HAT therapeutics). Most of the potent TbHK1 inhibitors were toxic to culture-grown BSF T.
brucei while not exhibiting toxicity towards mammalian cells, suggesting that they may be useful
lead compounds in the development of new therapies for African trypanosomiasis.

METHODS
Chemicals and Reagents. Clear 384-well microtiter plates were purchased from Greiner
(Monroe, NC) and used for all experiments. Glucose-6-phosphate dehydrogenase, βnicotinamide adenine dinucleotide (NAD+), adenosine triphosphate (ATP), lipoic acid (PubChem
SID 11532893) and glucose were purchased from Sigma (St. Louis, MO). Phosphoenol pyruvate
(PEP), ebselen (PubChem SID 856002) and glucosamine were obtained through VWR (West
Chester, PA) and dimethyl sulfoxide (DMSO) was purchased from Fisher (Pittsburgh, PA). The
following PubChem SID compounds were obtained from commercial vendors: 3716597,
24830882, 17386310, and 16952891 (Enamine/Kiev, Ukraine); 24797131 (Chembridge/San
Diego, CA); 14728414 and 17387000 (Specs/Delft, The Netherlands); 17507245
(Asinex/Moscow, Russia); and 24785302 (ChemDiv, San Diego, CA).

Compound Libraries. The library of pharmacologically active compounds (LOPAC) (1,280
compounds) was purchased from Sigma-Aldrich. The Pittsburgh Molecular Libraries Screening
Center (PMLSC) provided the 220,233 compound library screened for TbHK1 small molecule
inhibitors, which was made available as part of the NIH Molecular Libraries Roadmap Initiative.
Cherry-picked compounds from the PMLSC library were supplied by BiofocusDPI (San
Francisco, CA).
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Purification of Bacterially Expressed TbHK1. For purification of bacterially expressed TbHK1
(rTbHK1), a previously described protocol [8] was modified to increase yield. Briefly, a starter
culture of E. coli M15(pREP) harboring pQE30 (Qiagen, Valencia, CA) with the TbHK1 gene
cloned in frame of a 6-His tagging sequence was grown in ECPM1 [9] and then inoculated into a
5 L bioreactor (Biostat B, B. Braun Biotech International, Allentown, PA) and grown at 37oC.
At OD600 between 3-5, the culture was induced with IPTG (0.8 mM), grown without supplement
O2 (37oC, 16 hr), and cells collected by centrifugation (5000 x g, 20 min, 4oC). The pellet was
resuspended in lysis buffer (50 mM NaPO4, pH 8.1, 5 mM glucose, 150 mM NaCl, and 0.1%
Tween) and lysed by using a cell disruptor (Constant Cell Disruption Systems, Sanford, NC).
The resulting supernatant was applied (5 ml/min) to a 50 ml ProBind column (Invitrogen,
Eugene, OR) on a FPLC (GE Lifesciences, Piscataway, NJ) and protein eluted by gradient (5 to
250 mM imidazole) in lysis buffer. Fractions were screened using HK activity assays and
Western blotting and those containing rTbHK1 were pooled, concentrated, and applied to a
HiTrap SP HP column (GE Lifesciences, Piscataway, NJ).

Automated primary TbHK1 HTS and glucose-6-phosphate dehydrogenase coupled assays.
TbHK1 assays were an adaptation of a coupled enzyme HK assay to a 384-well format [8,10].
Briefly, test and control compounds (30 µM in 15 µL volume) were added to a 384 well black,
opaque microtiter plate using a Velocity 11 V-prep (Santa Clara, CA) for a final test compound
concentration of 10 µM. Negative (vehicle) controls contained 1% DMSO, positive controls
contained 133 mM glucosamine and IC50 controls contained 1.3 mM glucosamine (final well
concentrations). A mixture containing glucose (1.5 mM), ATP (1.05 mM), MgCl2 (4.5 mM),
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NAD+ (9 mM), glucose-6-phosphate dehydrogenase (G6PDH, 0.018 mUnits/µL) and
triethanolamine (TEA, 100 mM, pH 8.0) in a 15 µL volume was then added to each well of the
assay plate using a Perkin Elmer FlexDrop (Waltham, MA) followed by addition of rTbHK1 (1.5
ng/µl in 15µL volume). The 45 µL reaction mixture was incubated at RT for 2 hr and then
quenched with 5 µL EDTA (500 mM). The resulting signal, which remained stable for up to 5
hr after addition of stop reagent, was collected on a Molecular Devices SpectraMax M5
(absorbance at OD340)(Sunnyvale, CA).
To account for possible inhibition of the reporter enzyme in the primary coupled reaction,
putative inhibitors were screened to assess their activity against a G6PDH coupled assay.
Briefly, test and controls compounds were added to the wells of a 384 well assay plates as
described above. Negative (vehicle) controls contained 1% DMSO, positive controls contained
100 mM PEP and IC50 controls contained 8.6 mM PEP (final well concentrations). A mixture
containing glucose-6-phosphate (G6P, 0.6 mM) and NAD+ (1.8 mM) in a volume of 15 µL was
then added to each assay plate well. The reaction was initiated by addition of 15 µL G6PDH
(0.018 mUnits/mL) (for a final volume of 45 µl), incubated at RT for 1 hr, and then quenched
with 5 µl of EDTA (500 mM). The change in absorbance at OD340 was monitored as above.
Additional specificity assays were performed using human HK 4 (human glucokinase,
hGlk, GenBank accession no. BC001890) that was expressed from a cloned cDNA (OPEN
Biosystems, Huntsville, AL) in pQE30. After sequencing, the plasmid was transformed into E.
coli M15 (pREP) and cultures were grown to an OD600 of 0.9 in terrific broth and protein
expression induced (3 hr, 37°C) with 1 mM IPTG followed by purification by nickel-affinity
chromatography.
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Inhibition assays of lysate-derived TbHK. Parasite lysates from BSF parasites were prepared by
incubation (5 min on ice) of 1.5 x 107 cells in lysis buffer (0.1 M TEA, pH 7.4, and 0.1% Triton
X-100) supplemented with 1 mM PMSF, 5 µg/ml leupeptin, and 100 µg/ml TLCK. In triplicate,
cell equivalents (2 x 105) were incubated with increasing concentrations of inhibitor for 15
minutes at RT prior to initiation of the coupled reaction. In short, the 200 µl reactions included
50 mM TEA, pH 7.4, 33 mM MgCl2, 20 mM glucose, 5.25 mM ATP, 0.75 mM NADP, and 0.1
units of G6PDH, with kinetic analyses performed using KaleidaGraph 4.1 (Synergy Software,
Reading, PA).

T. brucei viability assay. To determine the impact of TbHK1 inhibitors on cell growth, we
seeded 5 x 103 BSF parasites (cell line 90-13, a 427 strain) into 96-well clear-bottomed
polystyrene plates in 200 µl HMI-9 supplemented with 10% fetal bovine serum and 10% Serum
Plus (Sigma-Aldrich, St. Louis, MO) and grown in the presence of compound (2 µl) or
equivalently diluted carrier for 3 days in 5% CO2 at 37oC. CellTiter Blue (Promega, Madison
WI) was added (20 µl) and the plates incubated an additional 3 hr under standard culture
conditions. Fluorescence emission at 585 nm was then measured after excitation at 546 nm in a
GENios microtiter plate reader (Phenix Research Products, Hayward CA). DMSO solvent was
maintained at or below 1%, with 1% causing a 16% reduction in cell number at the end of the
three day assay.
Procyclic form (PF) parasites (29-13, a 427 strain, 5 x 104/well) were grown in 96-well
clear-bottomed polystyrene plates in 200 µl SDM-79 for 2 days (5% CO2, 25oC) and then
CellTiter Blue (20 µl) added. Plates were then incubated for 1 hr under standard culture
conditions. Fluorescence of samples was then characterized as above.
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Mammalian cell-line and Leishmania promastigote specificity assays. Cell-based specificity
assays were performed as previously described [11]. Briefly, mammalian cell line and
Leishmania promastigote assays were performed in final volumes of 25 µL using our previously
described 384-well microtiter format [12]. All mammalian cell lines were cultured and
maintained in complete growth medium preparations according to ATCC specifications (ATCC,
Manassas, VA). Leishmania promastigotes were cultured as previously described [11]. A549
(1,000 cells/22 µL), IMR-90 (1,000 cells/22 µL), HeLa (1,000 cells/22 µL), MDA-MB-231
(3,000 cells/22 µL), Leishmania promastigotes (5,000 parasites/22 µL) were seeded into each
well of 384-well microtiter plates and test and control compounds (3 µl) were added to
individual wells. Vehicle and positive controls were 1% and 10% DMSO, respectively. For
mammalian cells, assay plates were incubated for 44-46 h at 37oC in the presence of 5% CO2 and
for the Leishmania promastigotes, assay plates were incubated for 44 h at 28oC with 5% CO2.
Five µL of CellTiter Blue reagent was added to each assay plate well and incubated for 2-4 h at
37oC with 5% CO2. Data were captured on a Molecular Devices SpectraMax M5 (excitation
A560; emission A590).

HTS data analysis and statistical analysis. Primary HTS data analysis and subsequent
compound IC50 calculations were performed using ActivityBase (IDBS, Guilford, UK) and
Cytominer (University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA). Structural
similarity of the confirmed inhibitors was determined using Leadscope software (Columbus,
OH). Additional visualization and statistical analysis were performed using GraphPad Prism
software 5.0 and Spotfire (Somerville, MA). The PubChem database
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(http://PubChem.ncbi.nim.nih.gov) was used to verify if the confirmed TbHK1 small molecule
inhibitors exhibited bioactivity in other assays.

In silico ADME/Toxicity analysis. Computational modeling tools were used to estimate the
bioavailability, aqueous solubility, blood brain barrier potential, human intestinal absorption, the
cytochrome P450 (i.e. CYP2D6) enzyme inhibition potential, mutagenicity, and hERG inhibition
of the confirmed TbHK1 inhibitors. The bioavailability, aqueous solubility, and human intestinal
absorption were estimated using the ADME Boxes v4.0 software (Pharma Algorithms, Toronto,
Canada), while mutagenicity and hERG inhibition were estimated with TOX Boxes v2.9
software (Pharma Algorithms, Toronto, Canada). The CYP2D6 inhibition and blood brain barrier
potential were predicted using Accord for Excel 6.2.2 (Accelrys, Inc, San Diego).

RESULTS
Validation of optimized HTS assay conditions using the LOPAC set. The TbHK1 coupled assay
was optimized and validated for HTS by screening the LOPAC set. Compounds were assayed in
duplicate at a single concentration (10 µM) and reproducibility between the duplicate screens is
represented in Fig. 1 (R2= 0.96). Average Z-factors were 0.69 ± 0.02 for the two LOPAC assays
demonstrating the robustness of the developed assay format [13]. Eighteen compounds inhibited
TbHK1 enzymatic activity ≥ 40% at 10 µM including myricetin, a structural analog of quercetin,
which was previously identified as a TbHK1 small molecule inhibitor (IC50 = ~85 µM) (Lyda
and Morris, unpublished). These data confirmed that our automated HTS assay conditions were
robust and could be used to identify compounds that inhibited TbHK1 activity.
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Figure A.1. Validation of the HTS by LOPAC screening.
Plot of percent inhibition for duplicate screen of the 1280 LOPAC compounds. LOPAC compounds
(blue), minimum control, which should equal ~100% inhibition of signal readout (red), IC50 control
compounds (yellow), and maximum control compounds, which should equal ~0% inhibition of signal
readout (green), are indicated.

Interrogation of 220,233 compounds for TbHK1 small molecule inhibitors. We next screened
220,223 compounds at a single concentration (10 µM) for small molecule inhibitors of TbHK1
(Fig. 2). The HTS assay performed robustly (average Z-factors of 0.80 ± 0.1) and identified 239
compounds as primary actives (>50% inhibition at 10 µM), for an overall hit rate of 0.1%. The
239 active compounds were cherry-picked, and the initial inhibitory activity confirmed in the
primary TbHK1 assay. Additionally, the compounds were tested against the reporter enzyme,
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G6PDH, to confirm that they did not interfere with the assay format. Following initial 20 point
IC50 value determinations using cherrypicked compounds, compounds with IC50 values < 50 µM
were obtained from commercial sources. The activity of the 13 resupplied compounds was
empirically determined to control for possible TbHK1 inhibitory effects associated with
compound library degradation. Ten small molecules confirmed with TbHK1 IC50 values < 50
µM while three compounds failed to inhibit TbHK1. Leadscope analysis of the 10 confirmed
TbHK1 inhibitors classified six compounds into a cluster of structurally related compounds
(cluster 1) while the remaining four compounds were classified as singletons (Table 1, Fig. 3).
Ebselen (SID 856002) was the most potent compound in cluster 1 with an IC50=0.05 ± 0.03 µM.
For the majority of the compounds IC50 values either improved or remained similar to cherrypicked compounds with the exceptions of SID 17386310 and SID 14728414 (Table 1) which
were 7.5 and 6.6-fold less potent, respectively, upon resupply (data not shown). Moreover, all
ten novel TbHK1 inhibitors were 20-17,000-fold more potent than londiamine, a previously
described TbHK1 inhibitor [4] and 2-1720-fold more potent than quercetin (Lyda and Morris,
unpublished).
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Figure A.2. Scheme depicting HTS interrogation of a 220,233 small molecule library for
TbHK1 inhibitors.
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Figure A.3. Structures of HTS Cluster 1 and Singleton Hits
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Additional experiments to assess the in vitro specificity included testing the compounds
against hGlk. The activity against hGlck was varied, with the cluster 1 compounds yielding a
spectrum of efficacy, from very low inhibition at 10 µM (for example, SID 17387000, with 6.7%
inhibition, Table 1) to near complete inhibition by ebselen (97.8% inhibition). Singletons also
demonstrated a spectrum of activity against hGlck with SID 22401406 and SID 14728414
having minimal impact on the enzyme while 17386310 was a more potent inhibitor (Table 1).
Moreover, data mining of the PubChem database (http://pubchem.ncbi.nlm.nih.gov/) determined
the frequency with which a compound was found to be active in other assays. In general, the
cluster 1 compounds were active in other assays more frequently than the singletons, with SID
17387000 the most frequently active (identified in 7.2% of the 238 assays in which it was
tested). Singletons, on the other hand, were less frequently active. For example, SID 14728414
was confirmed as an active in one of 216 assays (<1%) (Table 1).

TbHK1 small molecule inhibitors are toxic to BSF parasites. TbHK1 has previously been shown
to be an essential gene for BSF T. brucei [4], suggesting that inhibitors of the enzyme may be
promising lead compounds for therapeutic development. To initially explore this possibility, we
grew cultured BSF parasites in the presence of 10 µM compound and cell density monitored
after 72 hr (Table 1). The ten resupplied compounds were tested in this assay, with EC50s
determined for those that inhibited cell growth >50% at 10 µM (Table 1). Compounds in cluster
1 included two of the most potent anti-trypanosomal compounds, SID 17387000 and SID
24785302. Singletons were also toxic, with SID 17386310 being one of the most potent
compounds tested to date. Four molecules, including a member of cluster 1 (SID 3716597) and
three singletons (SID 22401406, SID 24797131, SID 14728414) inhibited TbHK1 but were not
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toxic to BSF at 10 µM. With the exception of ebselen, the resupplied anti-parasitic compounds
exhibited EC50 values that were 10-1000 fold lower than the TbHK1 IC50 values. This
discrepancy could result from other actions or concentration of the inhibitors in the glycosome,
which is a small peroxisome-like organelle where TbHK1 is located. Additionally, we have
found that RNAi of TbHK1, which reduces expression but does not necessarily ablate it, is toxic
to BSF parasites, suggesting that modest inhibition of cellular TbHK1 activity could be lethal to
the parasite [4].
To explore the likelihood of off-target whole parasite effects, we assessed the toxicity of
the TbHK1 inhibitors against PF parasites. Unlike BSF parasites, PF parasites can utilize both
amino acids and glucose for ATP production. This dynamic metabolism suggests that the PF
parasites may be less sensitive to TbHK1 inhibitors. Indeed, at 10 µM most of the resupplied
compounds had only a modest impact on PF parasite growth, inhibiting growth between 0-51%
when compared to control cell lines. Compounds toxic to T. brucei were also assayed against a
related kinetoplastid parasite, Leishmania. The Leishmania promastigotes were typically less
sensitive to the resupplied compounds (with EC50s >12.5 µM), with the exception of the cluster 1
compounds ebselen, SID 17387000, SID 24785302 and the singleton, SID 17386310. These
compounds had EC50 values against Leishmania between 1-5 µM in exponentially growing
parasites (Table 1). Moreover, our identified TbHK1 inhibitors have minimal impact on human
cell lines with EC50 values >12.5 µM, suggesting at least 400-fold greater toxicity toward
parasites for the most potent T. brucei cytotoxic compounds (Table A.1).
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Table A.1. HTS Cluster 1 and Singleton Hits
Leadscope
PubChem
PubChem Bioassay
Grouping
SID
Activity1
Cluster 1

Singletons

IC50 (µM)
Resupply

% Inhibition of
hGlck (10 µM)

BSF
EC50 (µM)

% PF Growth
Inhibition (10 µM)

L. major
EC50 (µM)

856002
(Ebselen)

344/44/22

0.05 ± 0.03

97.8 ± 0.1

2.9 ± 0.28

51 ± 0.16

4.1 ± 0.4

17387000

236/38/17

2.0 ± 0.5

6.7 ± 9.4

0.030 ± 0.067

48 ± 0.15

1.9 ± 0.2

24785302

170/21/11

4.2 ± 1.0

6.9 ± 4.2

0.042 ± 0.0028

47 ± 0.15

1.9 ± 0.2

3716597

318/29/18

9.3 ± 0.3

7.8 ± 7.1

> 10

27 ± 0.080

>12.5

24830882

171/12/7

16.9 ± 0.1

88.8 ± 4.9

0.83 ± 0.20

8.6 ± 0.030

>12.5

16952891

214/24/11

2.6 ± 0.2

44.9 ± 9.9

0.30 ± 0.079

47 ± 0.15

>12.5

22401406

184/5/2

2.3 ± 0.3

0.0

> 10

0.0

>12.5

24797131

175/6/2

11.4 ± 3.2

6.3 ± 8.8

> 10

0.0

>12.5

17386310

211/10/4

33.6 ± 10.2

70.3 ± 3.6

0.038 ± 0.0038

50 ± 0.15

2.6 ± 0.1

14728414

216/2/1

41.7 ± 3.0

1.9 ± 7.0

> 10

0.0

>12.5

1

As of 09/03/09. Number of bioassays in which the compound was
tested/number in which the compound was active/number in which the
compound has been confirmed as an inhibitor.

In silico predictions for the identified TbHK1 inhibitors. To investigate the chemical similarity
of our newly identified TbHK1 small molecule inhibitors to current treatments for African
sleeping sickness as well as previously described TbHK1 inhibitors, we performed a similarity
search using the Tanimoto coefficient. The data indicated that the TbHK1 inhibitors displayed
low levels of similarity with all compounds examined with the highest similarity being between
lonidamine and SID 16952891 (47%) (Table A.2). Thus, these results demonstrate that the
newly identified TbHK1 inhibitors are unique, either displaying no or very low similarity to
known TbHK1 inhibitors and current therapies for African sleeping sickness.
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Table A.2. Comparison of structural similarities of HTS hits to licensed compounds used
against HAT and to known TbHK1 inhibitors
Compound
Proposed Mode of Antiparasitic
TbHK1 Inhibitor
Similarity
Action1
(SID)
Coefficient2(%)
Pentamidine
Accumulation in the mitochondria,
17386310
31
DNA binding
Suramin

Inhibition of glycolysis

24830882

38

24797131

38

Melarsoprol

Inhibition of glycolysis Interaction
with thiols

24830882

43

Eflornithine

Polyamine biosynthesis (via
inhibition of ODC)

14728414

27

Lonidamine

TbHK1 inhibitor3

16952891

47

Quercetin

TbHK1 inhibitor4

24797131

38

1

Reviewed in (13).
Similarity coefficient was determined using the Tanimoto coefficient. Compounds with values greater than 80%
are considered highly structurally similar.
3
(4)
4
Lyda and Morris, unpublished
2

Additional in silico ADME-tox predictions indicated that all ten TbHK1 compounds had
an extremely low probability for being either a hERG channel inhibitor or mutagenic (data not
shown). Moreover, all compounds, except SID 3716597 were predicted to be moderately to
highly bioavailable and nine of 10 compounds displayed medium to very high blood brain barrier
(BBB) potential, with the majority of the cluster one compounds predicted to have high to very
high BBB potential (Table A.3). Six of 10 TbHK1 inhibitors were predicted to have no
inhibitory activity on CYP2D6 enzyme with the exceptions being cluster one compounds SID
3716597 and SID 24785301 and singletons SID 14728414 and SID 24797131 (Table 3). The
majority of the compounds had a predicted low aqueous solubility (Table 3), suggesting that if
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these compounds were to be used in future analogue development, they would need to be refined
to improve their aqueous solubility. Thus, based on empirically derived data and in silico
analyses, we focused on cluster 1 compounds for subsequent analyses.

Table A. 3. In silico ADME/Toxicity Analysis
Leadscope
Grouping
Cluster 1

Singletons

PubChem SID

Aqueous Solubility

Bioavailability

CYP2D6 inhibition

Blood brain
barrier

856002
(Ebselen)

Low

High

Non-inhibitor

High

17387000
24785302
3716597
24830882
16952891
22401406
24797131
17386310
14728414

Low
Low
Low
Good
Low
Extremely Low
Good
Good
Low

High
Moderate
Low
High
Moderate
Moderate
High
Moderate
Moderate

Non-inhibitor
Inhibitor
Inhibitor
Non-inhibitor
Non-inhibitor
Non-inhibitor
Inhibitor
Non-inhibitor
Inhibitor

High
Very High
Medium
High
Medium
Undefined
Medium
Medium
High

Further characterization of two structurally related cluster 1 TbHK1 small molecule
inhibitors. Ebselen, 2-phenyl-1,2-benzisoselenazol-3(2H)-one, was the most potent TbHK1
inhibitor (IC50 = 0.05 ± 0.03 µM) identified in our studies while the structurally related inhibitor
SID 17387000 (2-phenyl-1,2-benzisothiazol-3(2H)-one) was the next potent compound
identified with an IC50 = 2.0 ± 0.5 µM (Table 1). Analysis of the nature of TbHK1 inhibition
revealed that both ebselen and SID 17387000 were mixed inhibitors with respect to ATP, with Ki
values of 6.13 µM and 6.89 µM, respectively (Fig. 4). However, both ebselen and SID
17387000 exhibited comparable IC50 values against T. brucei lysate-derived TbHK1 enzymatic
activity with IC50 values of 0.43 ± 0.02 µM and 1.2 ± 0.12 µM respectively (Fig. 5). Thus, while
compound SID 17387000 was nearly as potent against lysate activity as the bacterially expressed
protein, ebselen was significantly less potent against parasite lysate-derived TbHK1 activity
(than the bacterially expressed protein). These results suggest that ebselen may be metabolized
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by cellular components or that lysate-derived TbHK1 may be associated with various cofactors
that result in less potent IC50 values. Ebselen was also a potent inhibitor of hGlck (97.8%
inhibition at 10 µM), while SID 17387000 had relatively little activity (6.7% inhibition) against
the kinase (Table 1). Moreover, ebselen was ~100-fold less active against BSF parasites (Table
1). Taken together, these data suggest that the subtle structural differences between the two
compounds result in remarkable changes in their pharmacological behavior.
Both ebselen and SID 17387000 are potent trypanocides, with EC50s of 2.9 ± 0.28 µM
and 0.030 ± 0.067 µM, respectively. To determine if indeed the toxicity to BSF parasites is
related to inhibition of cellular TbHK1, we measured the impact of the compounds on cellular
G6P levels after culturing the parasites in the presence of ebselen and SID 17387000 [14] (Fig.
5C). To reduce the likelihood that toxicity was impacting G6P levels non-specifically, we
limited the incubation period to 1 and 4 hours, while employing high doses (10 times the EC50)
of the compounds. Incubation with ebselen for either 1 or 4 hours led to a 56% or 70% reduction
in G6P, while SID 17387000 was less effective, reducing G6P levels 29% and 18% after 1 and 4
hours, respectively (Fig. 5C). While these observations suggest a direct impact on TbHK
activity, other off-target impacts could be ultimately responsible for toxicity.
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Figure A.4. Ebselen and SID 17387000 are mixed inhibitors of TbHK1 with respect to ATP.
Lineweaver-Burk plots of inhibition with ebselen (A.) or SID 17387000 (B.). Assays were performed as
described for cell lystates (see Materials and Methods) with ATP concentrations varied.
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Figure A.5. Ebselen and SID 17387000 inhibit TbHK activity from parasite cell lysate and cause a
reduction in cellular G6P levels in BSF parasites.
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Increasing amounts of (A.) ebselen or (B.) SID 17387000 were incubated with 2 x 105 BSF cell
equivalents for 15 min at RT and HK assays were performed as described in the Materials and Methods.
(C.) Growth in the presence of Ebselen or SID 17387000 causes a reduction in cellular G6P levels. BSF
parasites (1 x 107) were cultured for 1 or 4 hours in the presence of 30 µM or 1 µM (10-fold the EC50)
ebselen or SID 17387000 followed by lysate preparation and comparison of G6P levels to an equivalent
number of untreated parasites [14].

DISCUSSION
There are currently four drugs approved for treatment of HAT. However, suramin and
pentamidine, developed in 1921 and 1941, respectively, are not effective against the late stage of
disease that occurs when the parasite crosses the blood-brain barrier. Melarsoprol, which was
introduced in 1949, leads to fatal complications in 5-10% of patients receiving the drug [15].
The most recently developed drug, eflornithine, is only efficacious against T. b. gambiense, but
is curative for both the early blood-borne infection and the late stage of disease with central
nervous system involvement; delivery of eflornithine is difficult, as the compound must be
administered intravenously four times a day for 14 days (delivering ~360 g/patient).
A number of screens of chemical libraries have been undertaken to identify therapeutic
leads against the African trypanosome. These include a phenotypic screen that interrogated a
library of FDA-approved drugs for anti-trypanosomal activity [16], as well as screens developed
to identify inhibitors of essential parasite enzymes. A screen for UDP-Glc 4’-epimerase
inhibitors using a small natural products library [17] and a screen of a commercial 134,500
compound library for trypanothione reductase inhibitors [18] are two examples of target-based
screens used to identify lead compounds for therapeutic development. In the last few years,
TbHK inhibitors have been explored as potential anti-parasitic compounds. Previous efforts to
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identify TbHK inhibitors include the development of compounds based on models of the TbHK
structure (predicted from homology studies of the yeast structure), and exploring the activity of
HK inhibitors from other systems [4]. Here we have used a HTS of 220,223 compounds to
identify new inhibitors of the parasite enzyme.
In our screens, we have identified several novel inhibitors of TbHK1. One compound,
ebselen, was the most potent inhibitor from both the LOPAC validation screen and the HTS.
Ebselen is a lipid-soluble seleno-organic compound that has been employed in clinical trials to
assess its value in prevention of ischemic damage in brain hemorrhage and stroke [19,20].
Ebselen inhibits lipid peroxidation through a glutathione peroxidase-like action [21], but may act
through other mechanisms as well. Notably, a single oral dose (100 mg/kg) of ebselen yields
serum values of 4-5 µM [22] and brain levels of the drug reach 21% of plasma levels [23],
suggesting that the compound (or its derivatives) may be useful for both early and late stage
sleeping sickness therapy development.
Ebselen likely has polypharmacological effects on BSF parasites, as the compound is
known to inhibit a number of enzymes in addition to TbHK1, including the trypanosome UDPGlc 4’-epimerase [17]. Ebselen, unlike other cluster 1 compounds, has an IC50 that is
significantly lower than the EC50, suggesting its metabolism may be distinct from the sulfurbearing compounds. Alternatively, a cellular “sink” could be interacting with ebselen, thereby
lowering its effective concentration.
The remaining cluster 1 compounds have EC50s notably lower than their TbHK1 IC50s,
suggesting possible actions on other cellular targets. Alternatively, differences between the two
values could result from the concentration of the compound within the parasite (perhaps in the
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glycosome) or metabolism of the inhibitor to a more potent form. These hypotheses would seem
worthy of further investigation.
An ideal therapeutic drug for African sleeping sickness would target the parasite (while
perhaps enhancing host immune responses) and work at concentrations low enough to limit the
severity of side effects. In the search for potential drug targets, we have focused on the
trypanosome TbHK1, a protein that the parasite requires to make ATP and have identified
compounds that may serve as leads in for the development of therapeutics in the continuing fight
against the African trypanosome.
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